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The G protein-coupled receptor (GPCR) family is the largest group of homologous 
proteins in the human genome. GPCRs are of prime physiological and medical 
importance as the actions of a wide range of hormones and drugs are mediated by 
these receptors. The gonadotropin-releasing hormone (GnRH) receptor is a member 
of the GPCR family, and plays a central role in the reproductive system. GnRH 
analogues are used therapeutically in a number of human disorders. 
All GPCRs contain 7 largely a-helical transmembrane domains. An arginine residue 
located at the cytosolic boundary of the third transmembrane domain is conserved in 
all members of the rhodopsin-like subfamily of GPCRs, and is nearly always 
preceded by an acidic residue (DR motif). This arginine has been proposed to play.a 
critical role in receptor activation. In this thesis, the effects of mutating these 
residues (Asp 138 and Arg 139 respectively, in the mouse GnRH receptor) to neutral 
amide residues, on coupling of the mouse GnRH receptor, were examined. In 
addition, the relationship of coupling to internalization in these mutant receptors was 
explored. 
Mutation of Arg 139 to Gin (R139Q) resulted in an 8-fold decrease in affinity for GnRH, 
and a similar decrease in affinity for a GnRH antagonist. Interestingly, the R139Q 
GnRH receptor was overexpressed 6- to 1 0-fold compared with wild type. In spite of 
this increased receptor number, the R139Q mutant showed a 150-fold decrease in 
potency of GnRH for stimulation of inositol phosphate production, as well as a 
decreased maximal response, indicating poor coupling to its effector system, with a 
calculated coupling efficiency of 6% relative to wild type. The modulation of agonist 
binding by temperature in this mutant receptor was investigated. Low temperature 
has been previously reported to induce a conformation with high agonist affinity in 
some GPCRs, resembling the activated state, and it was therefore of interest to 
determine whether this uncoupled mutant would display this transition. Despite its 
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severe uncoupling, agonist binding of the R139Q mutant showed modulation by 
temperature similar to the wild type receptor. Receptor-mediated internalization of · 
GnRH agonist by the R139Q GnRH receptor was decreased to 38-52% of the wild 
type level and was not restored by protein kinase C activation with phorbol ester. 
These results indicate that the highly conserved Arg 139 residue of the GnRH receptor 
plays critical roles in both G protein activation and receptor internalization, but not in 
temperature modulation of agonist binding. 
The R139K, R139H and D138A GnRH receptor mutants showed markedly 
decreased agonist and antagonist binding, and agonist-stimulated inositol 
phosphate production, indicating either gross misfolding, and/or failure of expression 
of these mutant receptors. The D138N GnRH receptor showed normal agonist and 
antagonist binding affinities, and increased coupling efficiency and internalization, 
despite the evolutionary conservation of this acidic residue. The enhanced coupling 
efficiency supports the hypothesis that an ionic interaction between the Asp and Arg 
side chains of the DR motif holds the GPCR in the inactive conformation. 
The DAB cross-linking method was used for the first time for measuring the 
internalization of agonist- and antagonist-occupied GPCRs. This method utilizes the 
enzymatic activity of horse-radish peroxidase to polymerize 3, 3'-Diaminobenzidene 
in endosorries, with the consequent cross-linking of endosomal content proteins 
(including radioligand-GnRH receptor complexes) to the DAB polymer. Using this 
method, antagonist-occupied GnRH receptors were shown not to undergo 
internalization, suggesting that receptor activation is a critical determinant for GnRH 
receptor internalization. 
The chicken GnRH receptor is notable for having a cytoplasmic C-terminal tail, 
which is not present in the mammalian GnRH receptors. In order to investigate the 
role of the cytoplasmic tail of the chicken GnRH receptor in mediating its agonist-
promoted internalization, a series of mutant constructs were prepared, in which 
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portions of the cytoplasmic tail were deleted, or Ser and Thr residues point mutated 
to Ala. Internalization of the receptor-ligand complex was then assessed by 
measuring the rate of internalization of bound radioligand. Truncations of the 
cytoplasmic tail resulted in receptors that internalized GnRH agonist at a lower rate 
than the wild type chicken receptor. Point mutations were made to further localize 
the tail elements critical for the internalization process. The data indicate that rapid 
agonist-promoted internalization of the chicken GnRH receptor is mediated through 
elements in the cytoplasmic C-terminal tail, distal to or including Ser337. In addition, 
the results show that a Thr-Thr doublet located near the C-terminal end are the most 
important. Comparison of the data presented in this thesis with those obtained for 
other GPCRs shows that the motif Thr/Ser-Thr/Ser-lle/LeuNal may be an 
internalization sequence. Furthermore, these findings suggests that elimination of 
the cytoplasmic C-terminal tail during evolution of mammalian GnRH receptors may 
be related to its effects on internalization. 
The effects of co-expressing dynamin and a dominant-negative mutant of dynamin 
on agonist promoted internalization of the chicken GnRH receptor were also 
investigated. The results suggest that internalization of the chicken receptor 
proceeds via a clathrin- and dynamin-dependent pathway, while human receptor 
internalization is dynamin-independent. 
A simple mathematical model describing receptor trafficking was derived for the 
analysis of receptor internalization data. This model assumes that the rate of 
receptor degradation is small compared to the rates of receptor recycling and 
internalization, and can be neglected. On the basis of results obtained from 
photoaffinity-labeling studies of the mouse GnRH receptor, this assumption was 
justified. The covalent cross-link between the photoaffinity ligand 1251-[N-
azidobenzoyi-D-Lys6]GnRH and the GnRH receptor was shown to be stable enough 
to allow the measurement of the rate of intracellular degradation of the mouse GnRH 
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receptor, which was shown to have a half-life of 4.8 hrs, corresponding to a 
degradation rate of 0.24%.min-1. 
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GnRH RECEPTOR NOMENCLATURE 
The species of GnRH receptor is indicated by the first (lowercase) letter. m=mouse, 
h=human, and c=chicken. The mutation is indicated using the single-letter amino 
acid code. 
Example: mD138A refers to mutation of Asp138 to Ala in 
the mouse GnRH receptor 
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GENERIC RESIDUE NUMBERING 
The generic residue numbering system of Ballesteros and Weinstein (1996) is used 
in this thesis. In this system, the most conserved residue in a particular 
transmembrane domain is designated by the index 50. Thus the conserved Arg at 
the cytoplasmic side of helix 3 is numbered 3.50. The other residues are numbered 
in relation to the conserved residue. For example, the Asp directly adjacent to Arg3.50 
is denoted Asp3·49, while the Ser is denoted Ser3·51 . 
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1 INTRODUCTION AND REVIEW OF LITERATURE 
1.1 SUMMARY 
G protein-coupled receptors (GPCRs) represent a large family of integral membrane 
proteins that transduce extracellular stimuli to the cells interior. Cellular responses to 
agonists of GPCRs become desensitized (attenuated) over time. Following agonist 
exposure, most GPCRs studied to date undergo agonist-promoted internalization. 
The mechanisms of this desensitization and agonist-promoted internalization are 
incompletely understood, and are the subject of this thesis. 
In principle, desensitization could result from: (a) uncoupling of receptors from their 
cognate G proteins; (b) a decrease in the number of receptors on the cell surface as 
a result of their internalization (sequestration); (c) a decrease in the total cellular 
complement of receptors, which is referred to as downregulation and could result 
from decreased synthesis or increased degradation of receptors; (d) modulation of 
signaling downstream of the receptor (for example, concentration of G proteins or 
effector enzymes). 
The first part of this introduction (Section 1.2) reviews desensitization of GPCRs, 
while the second part (Section 1.3) reviews what is known about internalization of 
GPCRs. It discusses agonist-promoted internalization and examines some of the 
proteins that are implicated in this process. The relationship between agonist-
promoted internalization and G protein coupling is also explored. The final part of 
the introduction (Section 1.4) deals specifically with the GnRH receptor and reviews 
internalization, G protein coupling and desensitization in relation to its functioning. 
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1.2 DESENSITIZATION OF G PROTEIN-COUPLED RECEPTORS 
1.2.1 Homologous and heterologous desensitization 
Two types of desensitization may be. distinguished, based on the mechanism by 
which they attenuate signaling of GPCRs. Homologous desensitization requires 
agonist-occupancy and activation of the desensitized receptor. G protein-coupled 
receptor kinase (GRK)-mediated phosphorylation and arrestin binding is one well-
described mechanism for homologous desensitization (Section 1.2.2.1 ). 
Heterologous desensitization refers to the desensitization of receptors resulting from 
activation of different receptors, and does not require agonist occupancy of the 
desensitized receptor. Activation of second messenger-dependent kinases 
(PKA/PKC) is known to mediate heterologous desensitization of GPCRs (Section 
1.2.2.2). 
1.2.2 Molecular determinants of desensitization 
1.2.2.1. The G protein-coupled receptor kinases (GRKs) 
Six members of the GRK subfamily (Table 1) of Ser/Thr protein kinases have been 
identified and share 53-93% overall sequence homology (for review of functional and 
structural aspects see Sterne-Marr and Benovic, 1995). Unlike the second 
messenger-dependent kinases, there are no well-defined consensus sites for GRK-
mediated phosphorylation of GPCRs. Studies of GPCR phosphorylation are 
generally complicated by the fact that in many ·cases both GRKs and second 
messenger-dependent protein kinases contribute to phosphorylation of the same 
receptor. 
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Known receptor substrates 
rhodopsin, ~2-adrenergic 
~r. a.2A-. a.19-adrenergic, rhodopsin, m1 and m2 muscarinic, 
neurokinin-1, thrombin, dopamine, secretin, opioid, A2 and 
A3 adenosine, AT1A 
~2-,a.19-adrenergic, m2 muscarinic, neurokinin-1, thrombin, 
neurokinin-1, secretin 
~2-adrenergic, luteinizing hormone 
~2-,a.19-adrenergic, rhodopsin, secretin 
Two phosphorylation domains, one for PKA in the third intracellular loop and one for 
GRK2/3 in the cytoplasmic tail, have been identified on the ~2-adrenergic receptor 
(Hausdorff et al., 1989). Ozcelebi et al. (1996) have demonstrated that both PKC 
and GRKs are capable of phosphorylating the cholesystokinin-A receptor, depending 
in which cell line it was expressed. Furthermore, both PKC and GRK2 have been 
shown to phosphorylate the m1 muscarinic receptor (Haga et al., 1996). Similar 
results were reported for the AT1A receptor (Opperman et al., 1996). 
Many GPCRs contain several potential GRK phosphorylation sites in their 
cytoplasmic tails, while others with shorter cytoplasmic tails contain few or no serine 
and threonine residues. The latter group of receptors may have long third 
intracellular loops containing multiple serine and threonine residues which are 
putative sites for GRK-mediated phosphorylation. Indeed, deletion of the Ser/Thr-
rich region of the third intracellular loop of the a2A-adrenergic receptor, almost 
completely abolished receptor phosphorylation and prevented short term agonist-
promoted desensitization (Liggett et al., 1992). It is now known that the sites for 
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GRK-mediated phosphorylation of the a2A-adrenergic receptor are four consecutive 
Ser residues in its third intracellular loop (Eason et al., 1995). Similarly, the sites 
required for GRK-mediated phosphorylation of the m2 muscarinic receptor have 
been identified as serine and threonine residues within its third intracellular loop 
(Na~ata et al., 1994). It has also been demonstrated that GRK2/3 can phosphorylate 
the neurokinin-1 receptor (Kwatra et al., 1993). More recently it was reported that 
substance P induced homologous desensitization and internalization of the 
neurokinin-1 receptor in neurons, and that this may be mediated by GRK2 and 
GRK3 (McConalogue et al., 1998). 
Through in vitro phosphorylation studies, tentative GRK2 and GRK5 phosphorylation 
sites have been identified in the 13radrenergic receptor (Fredericks et al., 1996). 
However, a recent report in which these Serffhr residues were mutated to Ala has 
demonstrated that neither desensitization nor the extent of receptor internalization 
was affected (Seibold et al., 1998}, suggesting that sites other than those originally 
identified are involved. 
Phosphorylation of Serffhr residues within the cytoplasmic C-terminal tail of a 
number of GPCRs has been implicated in their desensitization (Bouvier et al., 1988; 
Lattion et al., 1994; Hukovic et al., 1998). In contrast, for other GPCRs this region is 
required for their agonist-promoted internalization and not desensitization (Benya et 
al., 1993; Huang et al., 1995; Thomas et al., 1995b). Interestingly, Widmann et al., 
1997 have reported that both homologous desensitization and agonist-promoted 
internalization of the glucagon-like peptide-1 receptor is dependent on 
phosphorylation at the same three serine doublets of the cytoplasmic C-terminal. 
The requirement of cytoplasmic tail Serffhr residues for luteinizing hormone 
receptor desensitization was demonstrated by truncating the receptor at position 
631. The resulting mutant was unable to desensitize (Sanchez-Vague et al., 1992). 
In contrast, a later study reported that when the cytoplasmic tail was truncated at 
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position 628, the truncated receptor desensitized to the same degree as the full-
length wild type receptor (Zhu et al., 1993). The authors speculated that the reason 
for this discrepancy may be as a result of the newly created bulky arginyl-arginine 
carboxyl terminus of the 631 stop truncation mutant, which could have conferred non-
specific desensitization on this recept~r. Apparently, positively charged polypeptides 
are able to non-specifically activate G proteins (Antonelli et al., 1991 ). 
In several studies, the role of GRKs in mediating desensitization has been 
established through the co-expression of either the kinase or a dominant-negative 
mutant thereof with a particular receptor. Pippig et al. (1993) demonstrated that f32-
adrenergic receptor desensitization was enhanced by the overexpression of GRK2. 
Similar findings were reported, following the co-expression of a GRK, for the f3 1-
adrenergic (Freedman et al., 1995), a.18-adrenergic (Diviani et al., 1996), a.2-
adrenergic (Jeweii-Motz and Liggett, 1996), thrombin (Ishii et al., 1994), AT1A 
(Opperman et al., 1996), A3 adenosine (Palmer et al., 1995), m2 muscarinic 
(Schlador and Nathanson, 1997), and 8-opioid (Pei et al., 1995) receptors. 
Furthermore, in a recent study the effect of co-transfection of GRKs 1-5 on secretin 
receptor desensitization was evaluated (Schetzline et al., 1998). It was reported that 
GRKs 2 and 5 were the most potent at mediating secretin receptor desensitization, 
with GRK3 having a partial effect and GRKs 4 and 6 no effect. 
Co-expression of a dominant-negative mutant of GRK2 was shown to prevent 
desensitization of the f32-adrenergic (Kong et al., 1994 ), 8-opioid (Pei et al., 1995), 
and K-opioid receptors (Raynor et al., 1994). Similar results were reported for f31-
adrenergic (Freedman et al., 1995), m2 muscarinic (Pals-Rylaarsdam et al., 1995), 
AT1A (Opperman et al., 1996), and A2 adenosine (Mundell et al., 1997) receptors, 
following co-expression of GRKs. 
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It has been observed that differential receptor trafficking and desensitization 
properties exist for the f.!·Opioid receptor, depending on the agonist activating the 
receptor (Zhang et al., 1998). It is suggested that these properties are related to the 
differential abilities of the various agonists to induce GRK-mediated f.!·Opioid 
receptor phosphorylation. Under normal expression conditions, both etorphine and 
morphine activated the receptor, but only etorphine stimulated its phosphorylation 
and consequent arrestin- and dynamin-dependent internalization (Zhang et al., 
1998). A recent study demonstrated that when GRK2 was overexpressed, morphine 
was also able to induce f.!·Opioid receptor phosphorylation, arrestin binding, 
desensitization, and agonist-promoted internalization (Zhang et al., 1998). 
The identity of the kinase(s) responsible for mediating m3 muscarinic receptor 
phosphorylation have eluded investigators for some time (Tobin et al., 1992; Tobin 
and Nahorski, 1993). Recently, it was demonstrated that m3 muscarinic receptors 
expressed in insect cells were phosphorylated by GRK2 in an agonist-dependent 
manner. This was the first demonstration that m3 muscarinic receptors could serve 
as substrates for GRKs (Debburman et al., 1995). A novel class of receptor kinase 
(designated MRK for muscarinic receptor kinase) that mediates agonist-dependent 
phosphorylation of the m3 muscarinic receptor has now been identified (Tobin et al., 
199Q_). 
1.2.2.2 The second messenger-dependent protein kinases (PKA/PKC) 
The second messenger-dependent protein . kinases participate in GPCR 
heterologous desensitization. GPCRs may contain phosphorylation sites for PKA, 
PKC, or calcium/calmodulin-dependent protein kinase, and some of these sites may 
lead to desensitization when phosphorylated (Lefkowitz, Stadel, and Caron, 1983; 
Lefkowitz and Caron, 1986, 1987; Sibley et al., 1986, 1987, 1988; Caron and 
Lefkowitz, 1993; Lefkowitz, 1993). In principle, it is possible that GPCRs are 
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phosphorylated by kinases of their ,own signaling ~scade, or by kinases activated 
• - • ......._ ' j ~ • • . • . -
by other receptors .. Thus heterologous desensitization is a potential means of "cross-
talk" between signaling pathways. Some of the possible modulatory loops are 
illustrated in Figure 1. 
The major mechanism of heterologous desensitization of adenylyl cyclase-coupled .. . ... "· . -~~ . - ' . . 
receptors is via phosphorylation by PKA. Early studies on GPCR desensitization 
·. t . .. .. 
demonstrated that PKA mediates the phosphorylation and heterologous 
I • ; > ' " ~ ~ 
desensitization of the ~2-adrenergic receptor (Stadel et al., 1983; Sibley et al., 1986, 
1987). Therefore, any hormone or .drug that leads to an increase in cAMP levels and 
• • t • !'-... • • 
adenylyl cy~lase activity, will result in the ~ctivat.ion of. PKA and subsequent 
phosphorylation and desensitization o( the ~2-adrenerg!c ~eceptor. Thus this type of 
' • • ' • J • 
regulation of GPCRs is defined as heterologous. . . 
PKC can also phosphorylate .the ~2-adrenergic rec~ptor as demonstrated by pre-
treatment of intact cells with .phorbol esters which directly,_activate PKC, leading to 
• I 
receptor phosphorylation and. desersitization (Sibley, et al., 1984). These results 
suggest that PKC, . which is activated by phospholipase C-mediated hydrolysis of 
'. ~ . ' 
phospholipids promoted ... by .a numbe~ qf recept~~s. can also contribute to the 
phosphorylation and heterologous de~ensitizatjon ,of the ~radrenergic receptor. 
Phosphorylation and desensitization· of the phospholipase C-coupled a1-adrenergic 
' <:,. ' ' • , - j • 
receptor was demonstrated following phorbol ester activation of PKC (Leeb-
Lundberg et al., 19.85). Bouvier et al. (1986) have· de~onstrated through peptide 
. . . ~ . . 
mapping stu~ies that botfl .. :PKC an~ PKA are capable of phosphorylating the a1-
adr~nergic r~ceptor.:· A rec.ent study testing wh·ether PKC .. phosphorylation is a 
mechanism by w~ich; t~e a2A-~drenergic receptor. can be regulated by other 
receptors; reported that. t~e selective activation.tof a1 8-adrenergic receptor co-
expressed with .the a2A-adr~nergic receptor, led to desensitization .of the latter (Liang 
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1.2.2.3 The arrestins 
The arrestin family has six members, including the visual and non-visual isoforms 
(Palczewski, 1994; Krupnick and Benovic, 1998). The arrestins bind preferentially to 
GRK-phosphorylated GPCRs (as opposed to second messenger- or non-
phosphorylated receptors) and mediate homologous or agonist-dependent 
desensitization by disrupting the interaction between activated receptor and cognate 
G protein (for a study of the kinetics of arrestin interactions with GPCRs see 
Gurevich et al., 1995). 
Mechanisms have been elucidated by which GRKs are specifically targeted to the 
membrane-bound receptors. These involve their modification by isoprenylation or 
palmitoylation and interaction with G protein ~Y subunits (Pitcher et al., 1992). In 
contrast, the mechanism(s) by which arrestins are targeted to the plasma membrane 
to bind and uncouple GPCRs remains unknown. Furthermore, the regions of GPCRs 
required for arrestin interaction have not yet been delineated. Ferguson et · al. 
(1996a) have suggested that neither the cytoplasmic tail nor GRK-mediated 
phosphorylation is an absolute requirement for interaction of either ~-arrestin-1 or~­
arrestin-2 with the ~2-adrenergic receptor. 
1.2.2.4 The MAP kinase pathway 
A recent study has reported that, in HEK293 cells expressing dominant-negative 
mutants of ~-arrestin or dynamin, ~2-adrenergic receptor-mediated activation of MAP 
kinase was completely blocked (Daaka et al., 1998). This suggests that GRKs and ~­
arrestins, which uncouple GPCRs and target them for agonist-promoted 
internalization as discussed below, are essential in the GPCR-mediated MAP kinase 
signaling cascade. It has also been suggested that some feedback contribution from 
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the MAP kinase cascade is required for J..L-Opioid receptor desensitization 
(Polakiewicz et al., 1998). 
1.3 INTERNALIZATION OF G PROTEIN-COUPLED RECEPTORS 
Although receptor-mediated endocytosis is commonly thought of as a mechanism for 
the uptake of nutrients (for example, low density lipoprotein and transferrin) bound to 
specific receptors, it is also important in regulating the protein composition of the 
plasma membrane, and as discussed above, plays a role in attenuating the 
responses of signal-transducing receptors by removing the ligand-receptor 
complexes from the cell surface. 
Cell surface receptors may be categorized into two types based upon their patterns 
of internalization. Receptors for nutrients such as those for low density lipoprotein 
and transferrin internalize and recycle back to the surface at essentially the same 
rate whether or not they are occupied by ligand (Trowbridge et al., 1993). They are 
constitutively clustered in coated pits and undergo rapid internalization in the 
presence or absence of ligand (Goldstein et al., 1985). In contrast, receptors such as 
the tyrosine-kinase receptors (for example, the epidermal growth factor receptor) 
and GPCRs are only concentrated in coated pits and internalized after binding 
ligand (Trowbridge, 1991 ). 
In GPCRs, several studies have reported that antagonist ligands are internalized 
slowly or not at all, compared with agonists, suggesting a requirement for receptor 
activation in this process (Hoelscher et al., 1991; Lutz et al., 1992; von Zastrow et 
al., 1994; Williams et al., 1998). No internalization ofV1 and V2 vasopressin (Lutz et 
al., 1992), and ~2-adrenergic receptors (von Zastrow et al., 1994) was detectable 
following the binding of antagonists. Deglycosylated human choriogonadotropin, 
which retained its ability to bind to the lutropin/choriogonadoropin receptor but was 
unable to stimulate the production of cAMP, was internalized at a much slower rate 
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than normal human choriogonadotropin (Hoelscher et al., 1991 ). Furthermore, 
antagonist-occupied gastrin-releasing hormone receptors did not undergo 
internalization, and treatment with PMA did not induce their internalization (Williams 
et al., 1998). These findings suggested that simple ligand binding is insufficient to 
initiate internalization of the ligand-receptor complex, and that agonist-induced 
receptor activation is a major determinant of the rate of internalization. Theoretical 
possible relationships between agonist occupancy and internalization are presented 
in Figure 2 
In contrast, Roettger et al. (1997) have provided evidence that the cholecystokinin 
receptor undergoes internalization in response to antagonist occupation. 
Furthermore, while receptor phosphorylation has been suggested as a trigger for 
receptor internalization (see below Section 1.3.2.2), no significant increase in the 
phosphorylation state of the cholecystokinin receptor was reported following 
antagonist exposure. Thus, antagonist-stimulated internalization of the 
cholecystokinin receptor appears to proceed independently of receptor 
phosphorylation. Rather, it was suggested that antagonist occupation leads to a 
conformational change or stabilizes a conformation of the receptor that exposes a 
domain which mediates its internalization (Roettger et al., 1997). Two antagonists of 
the V2 vasopressin receptor exerted different effects on receptor internalization, as 
determined by confocal fluorescence microscopy. In this study (Pfeiffer et al., 1998), 
the nonpeptidic antagonist did not induce any visible receptor internalization, 
whereas the peptidic antagonist induced a slow but substantial receptor 
internalization (Pfeiffer et al., 1998). 
Some uncoupled mutant receptors have displayed defective internalization (Strader 
et al., 1987; Cheung et al., 1989, 1990; Campbell et al., 1991; Lameh et al., 1992; 
Nussenzveig et al., 1993a; Hunyady et al., 1994c; Benya et al., 1994; Arora et al., 
1995, 1996, 1997; Dhanwada et al., 1996, Laporte et al., 1996), although this 
relationship has not held true in all cases (Hausdorff et al., 1990; Cheung et al., 
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1990; Lameh et al., 1992; Benya et al., 1993; Nussenzveig., 1993b). These results 
suggest that for some receptors, G protein coupling is necessary for efficient 
agonist-promoted internalization, and raises the question whether agonist-promoted 
internalization might be mediated by the activated effector system in these receptors. 
The role of the activated effector system in mediating agonist-promoted 
internalization remains largely unexplored, especially in the case of uncoupled 
receptor mutants. Support for the proposal that the activated effector system {Figure 
2) contributes to agonist-promoted internalization has come from studies showing 
that inhibition of G protein-phospholipase C interaction by the amino steroid U-
73122 results in decreased internalization of thyrotropin-releasing hormone receptor 
{Nussenzveig et al., 1993b), and muscarinic receptors (Thompson et al., 1991 ). 
1.3.1 Pathways of agonist-promoted internalization 
There are now 5 known independent pathways for endocytic internalization: the 
clathrin-dependent pathway, the caveolar pathway, a clathrin- and caveolar-
independent pathway, macropinocxtosis, and phagocytosis (Reizman et al., 1998). 
So far, the only common feature of these different pathways is the requirement for an 
intact actin cytoskeleton. The predominant pathway for the agonist-promoted 
internalization of GPCRs is via the clathrin-dependent pathway. Internalization into 
clathrin-coated vesicles (CCVs) has been described for the f3radrenergic (Von 
Zastrow and Kobilka, 1992), thrombin (Hoxie et al., 1993) , neurokinin-1 and gastrin-
releasing peptide (Grady et al., 1995a, b), and m1 muscarinic (Tolbert and Lameh, 
1996) receptors. 
Some reports have described a caveolin-dependent (or clathrin-independent) 
internalization mechanism for the f32-adrenergic and cholesystokinin-A receptors 
(Dupree et al., 1993; Roettger et al., 1995). Two distinct mechanisms for agonist-
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promoted GPCR internalization were reported in a study of J32-adrenergic and AT1A 
receptor internalization (Zhang et al., 1996a). This study reported that when clathrin-
coated pit formation was blocked by the overexpression of a dominant-negative 
dynamin mutant (see Section 1.2.2.3), it did not prevent the internalization of the 
AT1A receptor, while J32-adrenergic receptor internal_ization was markedly reduced. 
This strongly suggests that certain GPCRs have the ability to utilize an alternative 
(clathrin-independent) internalization pathway. The mechanism(s) of the clathrin-
independent pathway of internalization are unknown, but the existence of such a 
pathway, at least after inactivation of the clathrin pathway, is no longer in doubt. 
The term -caveolae is used to describe flask-shaped plasma membrane pits that are 
independent of clathrin coats (Peters et al., 1985). Caveolae, thought to be formed 
by the accumulation of the 22 kDa integral membrane protein caveolin, have been 
associated with the endocytic transport of solutes across the cell, rather than 
transport to endosomes, an activity usually associated with CCVs (Milici et al., 
1987). Although caveolin is proposed to be a component of the caveolar "coat", a 
lack of caveolin expression has not been shown to cause a lack of caveolae. Indeed, 
one study suggests that caveolin may be a regulatory component of caveolae, rather 
than necessary to maintain their structure (Fra et al., 1994). A report demonstrating 
an interaction between caveolin and G proteins (Li et al., 1995), suggests that 
caveolin could negatively regulate the activation state of G proteins, or put another 
way, stabilize G proteins in an inactive state. 
Therefore, it appears that in many cases receptor internalization can be 
accomplished by more than one pathway, but the preferred . mechanism of 
internalization utilized by a particular GPCR is probably dependent upon both 
receptor-specific structural determinants and the cellular environment in which it is 
expressed (Von Zastrow and Kobilka, 1992). The functional implications if any, of 
these independent mechanisms for agonist-promoted internalization are not known. 
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1.3.2 Molecular determinants of agonist-promoted internalization 
1.3.2.1 Clathrin, the AP-2 complex and its components 
The basic structures of the coats of CCVs are formed by hexagonal and pentagonal 
lattices made up by the functional cytosolic unit, the clathrin triskelion (Pearse and 
Robinson, 1990) (Figure 3). This unit consists of three heavy chains (180 kDa each) 
complexed with three light chains (30-35 kDa each). The heavy chains comprise two 
distinct domains, an amino-terminal globular domain, generally referred to as the 
terminal domain, which lies at the distal end of each triskelion leg (Figure 3). In the 
coated pit, the terminal domains are believed to be located beneath each triskelion 
vertex (centre) of the lattice above and to project toward the plasma membrane 
(Krupnick et al., 1997a, b) (Figure 3). The remaining domain forms the triskelion 
core, consisting of the vertex, the proximal leg, and a portion of the distal leg. One 
clathrin light chain is associated with each proximal leg (Pearse and Robinson, 
1990). 
CCVs also contain non-clathrin components, the adaptors. The two adaptor 
complexes that have so far been identified, are the AP-1 and AP-2 complexes (a 
relative of AP-1 and AP-2 has been recently discovered and termed AP-3, but this 
complex is thought to function independently of clathrin (Mellman, 1996). These 
complexes play a critical role in the attachment of clathrin to membranes (Mellman, 
1996). The AP-1 adaptor is a component of the trans-Golgi network clathrin coats 
and consist of four subunits: y- and ~1-adaptins, J.l1 and cr1. The AP-2 complex, 
found at the plasma membrane where it is associated with clathrin coats, also 
comprises four related subunits: a- and ~2-adaptins, J.l2, and cr2 (Pearse and 
Robinson, 1990; Mellman, 1996). It has been proposed that upon binding, the 
adaptor complexes could induce the membrane curvature that optimally facilitates 
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the clathrin-mediated formation of coated pits (Mellman, 1996). Apart from their role 
in linking the clathrin lattices to the plasma membrane, the a- and f32-adaptins have 
also been implicated in the recognition of sorting signals in the cytoplasmic tails of . 
many integral membrane proteins (Pearse, 1988; Glickman et al., 1989; reviewed in 
Mellman, 1996). More recent evidence suggests that J..L2 of the AP-2 ~omplex may be 
directly involved in sorting signal recognition (Ohno et al., 1995). Furthermore, a 
recent study has shown that the envelope glycoprotein (Env) of human 
immunodeficiency virus, type 1 (HIV-1 ), which undergoes rapid internalization, binds 
specifically to J..L2, as well as the complete AP-2 complex, via its cytoplasmic domain 
(Boge et al., 1998). 
1.3.2.2 The serine/threonine kinases and f3-Arrestins 
The idea that receptor phosphorylation might not only be required to uncouple 
GPCRs (see Section 1.2), but also play a critical role initiating receptor 
internalization, was first suggested by Sibley et al. (1986). 
There are conflicting reports concerning the relationship between GPCR 
phosphorylation and consequent receptor internalization. Some studies (Table 2A) 
have shown that ligand-induced phosphorylation of serine/threonine residues is 
needed for efficient internalization of receptor-bound hormone (Lameh et at., 1992; 
Benya et at., 1993; Moro et al., 1993; Wang et at. 1997, Widmann et al., 1997). 
Other studies (Table 28) have shown that phosphorylation is not involved in 
internalization (Cheung et al., 1989; Hunyady et al., 1994a; Holtmann et al., 1996), 
and indeed early reports argued against a role for phosphorylation in the 
internalization of the f32-adrenergic receptors (Bouvier et al., 1988; Hausdorff et al., 
1989; Campbell et al., 1991; Kong et al., 1994). 
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TABLE 2 STUDIES ADDRESSING THE RELATIONSHIP OF GPCR 
PHOSPHORYLATION TO INTERNALIZATION 














Ferguson et al., 1995, 1996a; Menard et al., 1996; 
Ruiz-G6mez and Mayor, 1997 
Tseng et al., 1995 
ltokawa et al., 1996 
Benya et al., 1993 
Widmann et al., 1997 
Richardson et al., 1998 
Wang et al., 1997 
Lameh et al., 1992; Mora et al., 1993 
Tsuga et al., 1994; Schlador and Nathanson, 1997; 
Pals-Rylaarsdam et al., 1997 
Hermans et al., 1996 
Huang et al., 1995 






Hunyady et al., 1994a 
Bouvier et al., 1988; Cheung et al., 1989; Hausdorff et al., 1989; 
Campbell et al., 1991; Kong et al., 1994 
Holtmann et al., 1996 
However, more recent studies of ~2-adrenergic (Ferguson et al. 1995, 1996a; Ruiz-
G6mez and Mayor, 1997) and m2 muscarinic (Tsuga et al. 1994; Schlador and 
Nathanson, 1997) receptors indicated that agonist-induced phosphorylation 
facilitates the internalization of these two receptors. The latter study reported that 
GRK2 overexpression enhanced m2 muscarinic receptor internalization, and 
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overexpression of a dominant-negative GRK2 mutant (the K220W mutant) markedly 
retarded its internalization (Tsuga et al., 1994). However, it now appears that the 
results of this study were dependent on the cell-type being used, since inhibition of 
internalization was seen when COS-7 cells were used, but not in BHK-21 and 
HEK293 cells (Pals-Rylaarsdam et al., 1997). 
A clear role for GRK2-mediated phosphorylation was demonstrated with the use of 
an internalization-defective B2-adrenergic receptor mutant (the Y326A mutant) 
(Ferguson et al., 1995, 1996a). Even though this mutant receptor did not serve as an 
efficient substrate for GRK2, when GRK2 was overexpressed, it completely restored 
the mutant receptor's phosphorylation and internalization defects. However, GRK2 
overexpression could not restore internalization when the putative GRK2 
phosphorylation sites were mutated in the Y326A mutant receptor (Ferguson et al., 
1995, 1996a). It has also been shown that the internalization of the B2-adrenergic 
Y326A receptor mutant can be restored by overexpression of any GRK that has the 
ability to phosphorylate this mutant (Menard et al., 1996). 
A role for GRK-mediated phosphorylation was also demonstrated in 0 2-dopamine 
receptor internalization (ltokawa et al., 1996). Furthermore, phosphorylation at 
Ser/Thr residues may mediate the internalization of the gastrin-releasing peptide, 
parathyroid hormone and parathyroid hormone-related protein, bombesin, and 
neurotensin receptors, since removal of their Ser/Thr-rich C-terminal cytoplasmic 
tails impairs their internalization (Benya et al., 1993; Huang et al., 1995; Tseng et 
al., 1995; Hermans et al., 1996). In addition, Richardson et al. ( 1998) have shown 
that a phosphorylation-deficient mutant of the interleukin-8 (IL-8) receptor A was 
resistant to IL-8-induced receptor internalization. 
A mechanism by which phosphorylation would facilitate internalization of GPCRs has 
been suggested (Ferguson et al. 1995, 1996a). B-arrestins, which bind to GPCRs in 
response to GRK-mediated phosphorylation, are proposed to act as adapter-like 
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molecules serving to couple the receptor to the cells endocytotic machinery 
(Ferguson et al. 1996a, Zhang et al. 1996). Ferguson et al. (1996a) reported that 
overexpression of either p-arrestin-1 or J3-arrestin-2 in HEK293 cells is sufficient to 
restore the ability of the f32-adrenergic Y326A receptor mutant to internalize. In 
addition, arrestin overexpression was able to restore the defective i_nternalization of 
a P2-adrenergic receptor mutant in which the cytoplasmic tail was truncated at Cys341 
to remove putative GRK phosphorylation sites (Ferguson et al., 1996a). The same 
study provided further evidence of a role for GRK-mediated receptor phosphorylation 
in promoting interactions with arrestins, since co-expression of small· amounts of 
GRK2 with arrestins enhanced the arrestin-dependent recovery of Y326A 
internalization (Ferguson et al., 1996a). 
Overexpression of GRK2 and p-arrestin-1 have been shown to synergistically 
promote m2 muscarinic receptor desensitization and internalization in JPEG-3 cells 
(Schlador and Nathanson, 1997). Furthermore, whereas the m2 muscarinic receptor 
was shown to undergo increased internalization when p-arrestin-1 and p-arrestin-2 
were overexpressed (Pals-Rylaarsdam et al., 1997), the internalization of m1, m3, 
and m4 muscarinic receptors was unchanged, even when a dominant-negative 
mutant of arrestin was used to interrupt endogenous arrestin function (Lee et al., 
1998), suggesting that m1, m3, and m4 muscarinic receptors utilize arrestin-
independent internalization pathways. In a recent study it was demonstrated that 
substance P, an agonist of the neurokinin receptor, induced internalization of 
neurokinin-1 receptor in neurons, and that this may be mediated by GRK2 and 
GRK3 in addition to p-arrestins-1/2 (McConalogue et al., 1998). 
Pitcher et al. (1998) have demonstrated that GRK2 is a microtubule-associated 
protein, and report that it specifically phosphorylates tubulin in vitro. These results 
suggest a new role for GRK2; as an effector of GPCR activation on cytoskeleton 
38 
organization. The implications of this finding on the internalization process of 
GPGRs are not yet clear. 
The ability of arrestins to interact with clathrin has been demonstrated (Goodman et 
a~ .• 1997; Krupnick et al., 1997a, b). These studies ~how that arrestin binds via its C-
terminus to the terminal domain of clathrin, and is colocalized with the ~2-adrenergic 
receptor during the early stages of endocytosis (Goodman et al., 1996). Since the 
terminal domain is oriented toward the plasma membrane in coated pits, and binds 
arrestins and AP-2 complexes, it appears that arrestin acts as the anchor 
responsible for GPCR recruitment to the coated pit. 
Recently, more information on the regulation of arrestin itself was reported (Lin et al., 
1997). This study demonstrated that ~-arrestin-1 is constitutively phosphorylated at a 
C-terminal Ser residue, after which it is recruited to the plasma membrane as a result 
of binding to agonist-occupied receptors. Once at the plasma membrane it becomes 
dephosphorylated in order to allow its interaction with clathrin and AP-2. Following 
receptor internalization, ~-arrestin-1 is rephosphorylated. From these observations it 
appears that arrestin function is regulated by its phosphorylation state. 
In summary, the main role of GRK-mediated phosphorylation in GPCR internalization 
seems to be to promote interactions with arrestins. Arrestins serve a dual regulatory 
role in the life cycle of GPCRs. They mediate rapid uncoupling by binding to GRK-
phosphorylated receptors, and they target the receptors for internalization via the 
clathrin-coated pit endosomal pathway where receptor dephosphorylation and 
resensitization can occur (discussed in Section 1.3.4.2). 
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1.3.2.3 Dynamin 
Dynamin, a 1 00 kDa GTPase, is now known to be a major component in clathrin-
mediated internalization and has been shown to bind to a-adaptin of the AP-2 
complex (Wang et al., 1995). Dyn?min catalyzes the GTP-dependent disconnectio~ 
of CCVs from the plasma membrane, by self-assembling into collar-like quarternary 
structures around the neck of the internalizing coated pit. It has been suggested that 
a concerted conformational change in these collars would bring about the 
disconnection of the budding vesicle from the plasma membrane (Hinshaw et al., 
1995; Takei et al., 1995). 
The importance of dynamin for the internalization of ~2-adrenergic receptors, has 
been demonstrated by the overexpression of a dominant-negative mutant of dynamin 
(the K44A mutant) which inhibited ~2-adrenergic receptor internalization (Zhang et 
al., 1996a). In contrast, in the same study AT1A receptor internalization did not 
require dynamin. These results show that while ~2-adrenergic receptors internalize 
via the clathrin-dependent pathway as discussed above, the AT1A receptor may be 
able to activate an alternative internalization pathway that is independent of both 
dynamin and ~-arrestin (Zhang et al., 1996a). To investigate whether muscarinic 
receptors internalize in a subtype-specific manner via the dynamin-dependent CCV 
pathway, the effect of overexpressing the dominant-negative K44A dynamin mutant 
on the internalization of m1, m2, m3, and m4 muscarinic receptors was tested 
(Vogler et al., 1998). It was shown that while m1, m3, and m4 muscarinic receptor 
internalization was blocked by dominant-negative dynamin, that of the m2 subtype 
was unaffected, suggesting that different internalization pathways can be utilized by 
GPCRs, even within a closely related receptor group. These results also suggest 
that internalization of m1, m3, and m4 muscarinic receptors occurs via a dynamin-
dependent, but arrestin-independent pathway (see Section 1.3.2.2 above, Lee et al., 
1998). 
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It has been shown that GTP-bound dynamin binds with high affinity to dissociated G 
protein f3y-subunits in neuroendocrine GH4C 1 cells (Liu et al., 1997). This 
-
interaction inhibits the GTPase activity of dynamin, and may favour endocytic vesicle 
formation (Liu et. al., 1991). Relevant to this, Takei et al. (1995) showed that the 
stabilization of dynamin in its GTP-bound state by GTPyS resulted in a lengthening 
of the vesicle neck to form long tubules as a result of progressive polymerization of 
dynamin. 
A further study on domain structure and intramolecular regulation of dynamin has 
shown that dynamin is a tetramer, that the C-terminal Pro- and Arg-rich domain and 
the pleckstrin homology (PH) domain are, respectively, the positive and negative 
regulators of dynamin self-assembly and GTPase activity. The a-helical region 
between these two domains, now called the GTPase effector domain (GED), 
interacts with the N-terminal GTPase domain to stimulate GTP hydrolysis (Muhlberg 
et al., 1997). 
1.3.2.4 The Rab proteins 
The Rab family of Ras-related GTPases play important roles in membrane docking 
and fusion (Hall, 1990). Two members of this family have been implicated in the 
regulation of constitutively internalizing receptors. Overexpression of RabS 
increases the rate of transferrin receptor internalization (Bucci et al., 1992), while an 
overexpression of Rab4 was shown to accelerate the rate of recycling of the 
transferrin receptor back to the cell surface (van der Sluijs et al., 1992). RabS is 
therefore rate-limiting for the constitutive internalization of transferrin receptors. It is 
the best-characterized of the Rab GTPases and is required for the fusion between 
coated vesicles and early endosomes (Bucci et al., 1992). Very little is known about 
the relationship between Rab proteins and the agonist-promoted internalization of 
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GPCRs. Moore et al. (1995) demonstrated that the agonist-promoted internalization 
of J32-adrenergic receptors proceeds in a clathrin-mediated and Rab5-dependent 
manner. These results suggest that the internalization pathways of constitutively 
internalizing receptors (for example, transferrin receptors) are also utilized by 
GPCRs, and it is possible that Rab5 may also be rate-l.imiting in the agonist-
promoted internalization of GPCRs. 
1.3.2.5 The Rho and Rae proteins 
The three mammalian Rho proteins (A, B, and C) and the two Rae proteins (1 and 2) 
are Ras-related GTP-binding proteins and are known to be involved in the 
organization and assembly of the actin cytoskeleton (Madaule and Axel, 1985; Hall, 
1993). Lamaze et al. (1996) have demonstrated roles for both Rho and Rae in the 
regulation of CCV formation and receptor-mediated endocytosis of the transferrin 
receptor through coated pits. A role for Rho but not Rae proteins in the control of 
constitutive fluid-phase endocytosis has been shown in Xenopus oocytes 
(Schmalzing et al., 1995). While there is as yet no evidence for a direct role of Rho 
and Rae in agonist-promoted internalization of GPCRs, their role in mediating 
endocytosis via clathrin-coated pits suggests their possible involvement. 
1.3.2.6 Ubiquitin 
It is well known that the modification of cytoplasmic proteins with polyubiquitiri chains 
targets them for recognition and degradation in the multisubunit multicatalytic 
proteolytic complex known as the 265 proteosome (Goldberg and Rock, 1992; 
Ciechanover, 1994). The ubiquitination of cell surface receptors was first reported 
for the growth hormone receptor (Leung et al., 1987), and there is now also ~vidence 
that the ubiquitination of the growth hormone receptor and its internalization are 
closely related events (Strous et al., 1996). 
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It has been shown that a GPCR expressed in S. cerevisiae, the a-factor receptor, 
undergoes agonist-promoted ubiquitin-dependent internalization (Hicke · and 
Reizman, 1996). As with many GPCRs, the a-factor receptor is constitutively 
internalized at a very slow rate in the absence of ligand. The binding of the peptide 
pheromone, a-factor, stimulates the signal transduction pathway, resulting in 
agonist-promoted internalization of the a-factor receptor. Reneke et al. (1988) and 
Hicke and Reizman (1996) have shown that in response to a-factor binding, the a.-
factor receptor becomes phosphorylated at cytoplasmic C-terminal tail Ser/Thr 
residues. Furthermore, the receptor becomes ubiquitinated at Lys residues within the 
cytoplasmic C-terminal tail. It was demonstrated that radiolabeled a-factor was not 
internalized in yeast mutants lacking the multiple enzymes required for ubiqitination, 
indicating that ubiquitination of the a-factor receptor is required for its internalization. 
Following the identification and mutational analysis of a nine amino acid 
internalization signal sequence (SINNDAKSS) in the cytoplasmic tail of the a-factor 
receptor, it was suggested that the serine residues within this sequence are critical 
sites for receptor phosphorylation, which in turn positively regulates receptor 
ubiquitination (Hicke and Reizman, 1996; Hicke et al., 1998). It is presently not clear 
how widely the ubiquitin internalization signal is utilized within the GPCR superfamily 
of receptors. 
1.3.3 Domains of GPCRs involved in agonist-promoted internalization 
1.3.3.1 The DRYXXV/IXXPL sequence of the second intracellular loop 
The rhodopsin-like GPCRs exhibit conservation of certain residues in their 
transmembrane domains, which allows alignment of receptors within this family 
(Probst et al., 1992). An Arg residue, designated Arg3·50 according to the generic 
residue numbering system of Ballesteros and Weinstein (1996), located at the 
interface between the third transmembrane domain and the cytoplasm, is conserved 
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in all members of the family, and is nearly always preceded by an acidic residue 
(Asp or Glu), and frequently followed by a Tyr (DRY motif). Because of its high 
degree of conservation, and its location at the membrane-cytoplasm interface, the 
Arg residue within this motif has been proposed to play a critical role in receptor 
activation (Oiive_ira et al., 1994; Scheer et al., 1996). 
Evidence in support of a central coupling role for Arg3·50 has come from site-directed 
mutagenesis of this residue, substitution of which has been consistently shown to 
result in uncoupling in several GPCRs (Franke et al., 1990, 1992; Ohyama et al., 
1992; Min et al., 1993; Rosenthal et al., 1993; Benya et al., 1994; Zhu et al., 1994; 
Jones et al., 1995; Dhanwada et al., 1996). In contrast, mutation of the preceding 
acidic residue Asp3'49/Giu3.49 has produced a spectrum of results, ranging from 
complete abolition of coupling (Fraser et al., 1988) to constitutive activation of the 
effector system (Sakmar et al., 1989; Scheer et al., 1996). 
A recent computational modelling study by Ballesteros and co-workers (Ballesteros 
et al., 1998) suggests that the orientation of the Arg3·50 side-chain is modulated by 
conserved residues within TM3 surrounding Arg3·50• In particular, it is proposed that 
the inactive receptor conformation is stabilized by an ionic interaction between 
Glu/Asp3.49 and Arg3·50, and that the Glu/Asp3.49 becomes protonated upon receptor 
activation allowing the Arg3·50 side-chain to be released and to participate in G 
protein activation. The strong conservation of the acidic residue at position 3.49 in 
GPCRs could imply that its protonation forms part of a general mechanism for 
receptor activation. The orientation of Arg3·50 that is required for efficient receptor-G 
protein interaction is supported by a highly conserved f3-branched lie residue (lle3.54) 
in the a.-helical turn following Arg3·50• This model suggests that the conserved 
residues surrounding Arg3·50 act like a cage that surrounds the Arg and affects its 
orientation, and predicts that disruption of the Arg-cage will impair receptor function 
(Ballesteros et al., 1998). 
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1.3.3.2 The serine/threonine-rich third intracellular loop 
A Serrfhr-rich region in the middle of the third intracellular loop of the m1 muscarinic 
receptor has been shown to be critical for its efficient agonist-promoted 
.internalization (Maeda et al., 1990; Arden et al., .1992; Lameh et al., 1992; Moro et 
al., 1993). In addition, when residues 264-394 of the third intracellular loop of the m4 
muscarinic receptor are deleted or a membrane proximal Thr (Thr399) mutated to Ala, 
a markedly impaired internalization rate is observed (Van Koppen et al., 1994, 
1995). The above studies all involved the removal or disruption of PKA 
phosphorylation sites. These observations provide evidence that receptor 
phosphorylation may play a role in muscarinic receptor internalization. 
In contrast, in the case of the P2-adrenergic receptor, the third intracellular loop does 
not seem to be critical for internalization, but rather for receptor-G protein coupling 
(Cheung et al., 1990; Hausdorff et al., 1990). Similarly, Nakamura et al. (1998) has 
recently shown that agonist-induced phosphorylation at Serrfhr residues in the third 
intracellular loop of the rat follitropin receptor facilitates its uncoupling, but 
phosphorylation of these residues is not necessary for its agonist-promoted 
internalization. This study also demonstrated that the first intracellular loop is 
phosphorylated and that this phosphorylation is required for receptor internalization, 
but it is uncertain whether phosphorylation of the first only or both the first and third 
intracellular loops is necessary (Nakamura et al., 1998). 
1.3.3.3 The NP(X)2,a Y motif of the seventh transmembrane domain 
The highly conserved Tyr residue in this motif in TM7 of a.1 e-adrenergic (Wang, J. et 
al., 1997), P2-adrenergic (Barak et al., 1994; Ferguson et al., 1995), and GnRH 
(Arora et al., 1996) receptors was shown to be important for internalization. 
However, this motif is not required for internalization of the gastrin-releasing peptide 
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(Slice et al., 1994) and AT1A (Hunyady et al., 1994c, 1995; Thomas et al., 1995b; 
Laporte et al., 1996) receptors, suggesting that this sequence does not represent a 
universal internalization signal for GPCRs. 
Interestingly, the rapid internalization of a non-GPCR receptor, the low density 
' ' 
lipoprotein receptor, requires a tetrapeptide sequence motif similar to the NP(X)2,3Y 
motif of GPCRs. The NPXY sequence, which is conserved in low density lipoprotein 
receptors from six species and in two other members of the low density lipoprotein 
receptor gene family, is required for their rapid internalization. Furthermore, this 
motif is also found in the cytoplasmic domains of the epidermal growth factor and 
insulin receptors, suggesting that it may play a role in internalization of these 
receptors (Trowbridge, 1991 ). 
1.3.3.4 The cytoplasmic C-terminal tail 
Reports demonstrating a role for the cytoplasmic C-terminal tail in agonist-promoted 
internalization of GPCRs are numerous (see Table 3). Elements of the cytoplasmic 
tails of the AT1A (Hunyady et al., 1994b; Chaki et al., 1994; 8almforth et al., 1995; 
Thomas et al., 1995; Conchon et al., 1998), human 81 and 82 kinin (Faussner et al., 
1998), J32-adrenergic (Campbell et al., 1991; Hausdorff et al., 1991; Gabilondo et al., 
1997), bombesin (Tseng et al., 1995); cholesystokinin-A (Go et al., 1998), gastrin-
releasing peptide (8enya et al., 1993), glucagon-like peptide-1 (Widmann et al., 
1997), Histamine H2 (Fukushima et al., 1997), interleukin-8 (Prado et al., 1996), 
lutropin/choriogonadotropin (Rodriguez et al., 1992; Wang et al., 1997; Lazari et al., 
1998), neurotensin (Chalbry et al., 1995; Hermans et al., 1996), opioid receptor 
family (Trapaidze et al., 1996; Chu et al., 1997; Koch et al., 1998), parathyroid 
hormone (Huang et al., 1995), platelet-activating factor (Le Gouill et al., 1997; Ishii 
et al., 1998), thrombin (Shapiro et al., 1996), and thyrotropin-releasing hormone 
(Nussenzveig et al., 1993a; Ashworth et al., 1995) receptors, have been implicated 
in mediating their agonist-promoted internalization. 
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TABLE 3 STUDIES DEMONSTRATING A ROLE FOR THE CYTOPLASMIC C-
TERMINAL TAIL IN GPCR INTERNALIZATION 
Receptor 















Hunyady et al., 1994b; Chaki et al., 1994; Balmforth et al., 1995 
Thomas et al., 1995a,b; Conchon et al., 1998 
Faussner et al., 1998 
Campbell et al., 1991; Hausdorff et al., 1991; Gabilondo et al., 1997 
Tseng et al., 1995 
Go et al., 1998 
Benya et al., 1993 
Widmann et al., 1997 
Fukushima et al., 1997 
Prado et al., 1996 
Rodriguez et al., 1992; Wang et al., 1997; Lazari et al., 1998 
Chalbry et al., 1995; Hermans et al., 1996 
Trapaidze et al., 1996; Chu et al., 1997; Koch et al., 1998 
Huang et al., 1995 
Le Gouill et al., 1997; Ishii et al., 1998 
Shapiro et al., 1996 
thyrotropin-releasing hormone Nussenzveig et al., 1993a; Ashworth et al., 1995 
1.3.4 Function and biological role of agonist-promoted internalization 
Internalization of GPCRs into intracellular compartments following agonist exposure 
has potential relationships with other aspects of GPCR function. The possible 
relationships between receptor activation, receptor-G protein coupling, second 
messenger production, and agonist-promoted internalization are depicted 
schematically in Figure 2. In the next sections, the relationships of GPCR 
internalization to desensitization and resensitization are considered. 
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1.3.4.1 Sequestration, downregulation and desensitization 
Internalization of GPCRs may contribute to desensitization as a result of the removal 
of receptors from the plasma membrane, thereby making them inaccessible to 
agonists (sequestration). Internalization was orig.inally proposed to be a mechanism 
for desensitization based on the observation that the light membrane fraction 
containing internalized f32-adrenergic receptor did not contain Gs (Waldo et al., 1983) 
Several studies have reported that pharmacological agents that inhibit 
internalization, but do not disrupt GPCR signaling, prevent desensitization (Yu et al., 
1993; Pippig et al., 1995; Garland et al., 1996). In addition, when thyrotropin-
releasing hormone receptor internalization was blocked by either overexpression of 
dominant-negative mutant dynamin, hypertonic sucrose solution, or the removal of 
the receptor's cytoplasmic tail, desensitization failed to occur for the truncated 
receptor only (Yu and Hinkle, 1998), suggesting that the cytoplasmic tail, which is 
required for receptor internalization, is additionally required for this receptor's 
desensitization. Perhaps cytoplasmic tail phosphorylation at Ser!Thr residues is a 
feature of both internalization and desensitization of the thyrotropin-releasing 
hormone receptor. 
In contrast, a mutant f32-adrenergic receptor and a cytoplasmic tail truncated platelet-
activating factor receptor, both of which were defective for internalization, were 
shown to desensitize normally (Barak et al., 1994; Ishii et al.,1998). Similar results 
have been reported for m3 muscarinic and AT1A receptors (Tobin et al., 1992; 
Thomas et al., 1995). For a number of GPCRs including the m2 muscarinic (Pals-
Rylaarsdam et al., 1995), secretin (Holtmann et al., 1996), and neurokinin-1 
(Garland et al., 1996) receptors it appears that internalization and desensitization 
are independent distinct processes. These results suggest that agonist-promoted 
internalization is an important mechanism of receptor desensitization in some 
GPCRs, while other receptors utilize desensitization mechanisms independent of 
internalization. 
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Internalization may contribute to downregulation if the internalized receptors are 
more rapidly degraded (Hertel et al., 1985). Downregulation is defined as a 
decrease in the total number of receptors in a cell, and has often been observed as 
a result of long-term agonist exposure. In two recent studies, it was reported that 
agonist-promoted internalization of the ~Tadrenergic (Gagnon et al., 1998) and the 
m2 muscarinic (Tsuga et al., 1998) receptors was partly responsible for influencing 
their downregulation. An earlier study by Hausdorff et al. (1991) showed that a ~T 
adrenergic receptor mutant that was defective for internalization, displayed a wild 
type pattern of downregulation. These studies demonstrate that downregulation can 
be partly influenced by the internalization of receptors via the clathrin-coated pit 
endosomal pathway into lysosomes, where they are degraded. 
1.3.4.2 Resensitization 
It has been proposed that one of the roles for agonist-promoted internalization may 
be to mediate receptor dephosphorylation and resensitization (Yu et al., 1993; Barak 
et al., 1994; Garland et al., 1996). When ~2-adrenergic receptor internalization was 
inhibited by pharmacological treatments, such as hypertonic sucrose or 
concanavalin A it was shown that both dephosphorylation and resensitization was 
prevented (Pippig et al., 1995). Other studies have also suggested a role for agonist-
promoted internalization in accelerating the recovery from desensitization. Agonist-
promoted internalization of the neurokinin-1 (Garland et al., 1996) and a 18-
adrenergic (Fonseca et al., 1995) receptor is critical for their resensitization. lri 
addition, it was recently demonstrated that the cytoplasmic tail of one of the two 
isoforms of the rat !l-opioid receptor (the MOR1 8 isoform) facilitates its CCV-
mediated endocytosis which, in turn, promotes accelerated receptor resensitization 
(Koch et al., 1998). Moreover, an internalization-defective platelet-activating factor 
receptor lacking its cytoplasmic tail, showed no evidence of resensitization (Ishii et 
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al., 1998). In contrast, a C-terminal cytoplasmic tail truncation mutant of the 
thyrotropin-releasing hormone receptor that displayed blocked agonist-promoted 
internalization, was able to resensitize at a normal rate (Yu and Hinkle, 1998). 
1.3.5 A model for agonist-promoted internalization 
Ferguson et al (1996b) incorporated the general conclusions of the literature 
reviewed above in a model for GPCR trafficking in response to the binding of an 
agonist (Figure 4). 
Agonist binding results in activation of the receptor and consequent receptor-G 
protein coupling. Following the exchange of GOP for GTP on the G protein a 
subunit, the Ga and G13Y subunits dissociate leading to activation of the receptor's 
effector system. The receptor is then phosphorylated by GRKs. In the case of GRK2 
and GRK3, G
13
r is required to translocate the GRK to the plasma membrane. 
Receptor phosphorylation promotes the binding of arrestins, an event that targets 
the receptor for dynamin-dependent internalization via the clathrin-coated pit 
endosomal pathway where receptor dephosphorylation, release of receptor-bound 
arrestin and resensitization can occur. Acidification of the endosome leads to 
dissociation of the agonist (which can then undergo lysosomal degradation). The 
GPCR is then transported back to the cell surface where it is again able to bind 
agonist (Ferguson et al., 1996b). 
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1.4 THE GONADOTROPIN-RELEASING HORMONE RECEPTOR 
1.4.1 Introduction 
. The hypothalamic decapeptide GnRH (for structure see Table 4) is the central 
regulator of the reproductive system, acting via receptors on pituitary gonadotrope 
cells. GnRH receptors from mouse, rat, human,. sheep and cow are members of the 
rhodopsin-like family of GPCRs (Reinhart et al., 1992; Tsutsumi et al., 1992; Kakar 
et al., 1993; Kaiser et al., 1992; Chi et al., 1993; llling et al., 1993) and are coupled 
via Gqt11 to activation of phospholipase C, leading to calcium signaling (McArdle et 
al., 1992; Stojilkovic and Catt, 1992; Tse and Hille, 1992; Stojilkovic et al., 1994; 
Stojilkovic and Catt, 1995; Sealfon et al., 1997) and the release of gonadotropins by 
regulated exocytosis (van der Merwe et al., 1989; Davidson et al., 1991; Tse et al., 
1993). 
The mammalian GnRH receptor has a number of unique structural features (Figure 
5). These include the presence of an unusually long and highly basic first 
intracellular loop, a reversed arrangement of the highly conserved Asp of TM2 and 
Asn of TM7 (Zhou et al., 1994), replacement of Tyr for Ser in the highly conserved 
DRY motif at the cytoplasmic end of TM3, and in the case of mammalian GnRH 
receptors, the absence of a C-terminal cytoplasmic tail. In contrast, Gr:tRH receptors 
in non-mammalian species such as the catfish (Tensen et al., 1997), goldfish, frog, 
and chicken (Troskie et al., 1997) possess cytoplasmic tails like all other GPCRs 
(Figure 6). 
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TABLE 4 PRIMARY STRUCTURE OF GnRH ANALOGS USED IN THIS THESIS 
Analog Sequence 
Mammalian GnRH pGiu-His-Trp-Ser-Tyr-Giy-Leu-Arg-Pro-GiyNH2 
[O-Aia6-N-MeLeu7, 
Pro9-NEt]GnRH pGiu-His-Trp-Ser-Tyr-0-Aia-N-MeLeu-Arg-ProNEt 
[His5, 0-Tyr1GnRH pGiu-His-Trp-Ser-His-0-Tyr-Leu-Arg-Pro-GiyNH2 






1.4.2 Agonist-promoted internalization of the GnRH receptor 
The first demonstration of agonist-promoted internalization of the GnRH receptor 
was that of Hopkins and Gregory (1977), who utilized a GnRH analog coupled to 
ferritin. When dissociated pituitary cells were incubated with the analog, an even 
distribution of ferritin particles over the gonadotrope cell surface was observed under 
the electron microscope. After 15 min of incubation, the bound conjugates became 
aggregated and then formed clusters, which were subsequently internalized by 
endocytosis. Later, a biologically active rhodamine derivative of [D-Lys6]GnRH was 
used to study the uptake of the fluorescent peptide by pituitary cells (Hazum et al., 
1980; Naor et al., 1981 ). It was demonstrated that at first, the fluorescence was 
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evenly distributed over the cell surface. After 20 min of incubation, the rhodamine-
GnRH tracer localized to fluorescent aggregates at one pole of the pituitary cells, a 
similar observation to that of Hopkins and Gregory (1977). Internalization of the 
fluorescent tracer became evident after 30 min. Similar observations were reported 
by Childs et al. (1983) with the use of a [biotinyi-O-Lys6]GnRH derivative. 
Pelletier et al. (1982) and Ouello et al. (1983) utilized autoradiography to examine 
the fate of radioiodinated GnRH agonist following internalization, and demonstrated 
that the peptide was delivered to the Golgi region and lysosomes by vesicular 
transport. Utilizing [O-Lys6]GnRH coupled to electron-opaque markers (colloidal gold 
or ferritin), Jennes et al. (1983) demonstrated that following internalization, the 
derivatives were routed to lysomes either directly or after passage through the Golgi 
apparatus. A later study compared the route and rate of internalization of GnRH'in 
granulosa and pituitary cells (Childs et al., 1986). The GnRH receptor was localized 
with [biotinyi-O-Lys1GnRH, followed by avidin~gold or avidin-biotin-peroxidase 
complex staining. Binding and internalization of the [biotinyi-O-Lys6]GnRH occurred 
rapidly for both cell types, while the initial processing of the peptide subsequent to 
internalization appeared to be different, with the [biotinyi-O-Lys6]GnRH being rapidly 
transferred to the Golgi region in gonadotrope cells, suggesting a pathway for 
receptor recycling. In contrast, in granulosa cells the processing appeared to 
proceed from vesicles to endosomes, and only much later to the Golgi region (Childs 
et al., 1986). 
The development of photoaffinity labeling provided an important experimental tool 
for the detection and isolation of membrane components. A photoaffinity derivative of 
GnRH, [N-azidobenzoyi-O-Lys6]GnRH (see Table 4) (Hazum, 1981a, b), was used 
for GnRH receptor localization studies (Hazum et al., 1982a, b, 1984, 1985, Schvartz 
and Hazum, 1987). The major advantage of this approach was that the covalent 
attachment of the hormone to the receptor following photolysis allo~ed detection of 
the receptor-hormone complex throughout the cell. When dispersed rat pituitary cells 
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were incubated with 1251-[N-azidobenzoyi-D-Lys6]GnRH for 90 min at 4°C and 
subsequently photolyzed, most of the label remained associated with the cell 
surface membrane, while incubation for various time periods at 37°C followed by 
photolysis resulted in internalization of the derivative (Hazum et al., 1982a, b). 
The photoaffinity labeling of GnRH receptors of plasma membrane preparations 
from rat pituitary cells resulted in the identification of a single specific band with an 
apparent molecular weight of 60 kDa (Hazum, 1981 b). Later photoaffinity labeling 
studies (Hazum and Nimrod, 1982a, Hazum and Keinan, 1984, !washita and Catt, 
1985) have demonstrated that GnRH receptors in the ovary and the testis, differ in 
size from that of the pituitary. The differences in size are due to different degrees of 
glycosylation in various cell types and species of mammal (Davidson et al., 1995, 
1996, 1997). 
Schvartz and Hazum (1987) used the [N-azidobenzoyi-D-Lys6]GnRH derivative to 
follow the intracellular pathways of GnRH receptors subsequent to their 
internalization. In that study (Schvartz and Hazum, 1987), the site for GnRH receptor 
degradation appeared to be lysosomes, since pre-treatment with the lysosomotropic 
agents, chloroquine and methylamine, resulted in decreased receptor degradation. 
Receptor recycling was demonstrated on the basis of results obtained following 
treatment of the photaffinity labeled GnRH receptors with trypsin. A proteolytic 
fragment, characteristic of cell surface receptors, was obtained at all time-points 
measured, suggesting a rapid recycling pathway. It was postulated that the pathway 
of GnRH receptor recycling could involve passage through the Golgi apparatus and 
then via secretory granules (Hazum et al., 1985, Schvartz and Hazum, 1987). 
Childs et al. (1986) compared the processing of GnRH in pituitary and granulosa 
cells (see above) showing that the primary point of processing in pituitary cells was 
the Golgi region, and also suggested that receptor recycling could proceed via 
secretory granules. Furthermore, based on the ineffectiveness of weak bases and a 
54 
proton ionophore (monensin) on GnRH receptor recycling, it was concluded that 
acidification of intracellular compartments was not essential for GnRH receptor 
recycling (Schvartz and Hazum, 1987). This result suggests also that GnRH 
dissociation from the receptor was not necessary for recycling to proceed. This is in 
contrast to the more classical recycling receptors such as those for low density 
lipoprotein and transferrin (Goldstein et al., 1985) which require endosome 
acidification for ligand-receptor dissociation, and subsequent receptor recycling. 
The requirement for GnRH receptor activation for its internalization has been studied 
in some detail, with conflicting results. An early investigation into the internalization 
of GnRH receptor antagonists (Hazum et al., 1983) demonstrated that a rhodamine 
labeled antagonist showed a similar pattern of internalization to rhodamine-GnRH 
agonist studied previously (Hazum et al., 1980). In addition, the antagonist used was 
able to induce receptor clustering on the cell surface, as seen for agonists. In 
contrast, Loumaye et al. ( 1984) reported that a different antagonist to that used by 
Hazum et al. (1983), was not internalized, suggesting that activation of GnRH 
receptors by agonist binding is necessary to initiate receptor-mediated 
internalization. When the above two studies were repeated in an independent 
laboratory (Jennes et al., 1986), the results indicated that both antagonists were 
internalized by receptor-mediated internalization. It was suggested that the presence 
of antagonist in intracellular compartments could simply be related to the basal rate 
of GnRH receptor turnover in the plasma membrane. Additional reports supporting 
prior receptor activation as a requirement for GnRH receptor internalization have 
come from Suarez-Quian et al. (1986) and Wynn et al. (1986). 
In the pituitary, it has been shown that internalization of GnRH receptors is not 
required for LH release, and that the system has a ongoing requirement for 
externally applied GnRH in order to sustain stimulated LH release (Conn and 
Hazum, 1981; Conn et al., 1981) 
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As reviewed in Section 1.3.3, most of the sequence motifs that influence the 
internalization of GPCRs are Serffhr-rich and are usually found in the third 
intracellular loop or C-terminal cytoplasmic tail of the receptor. Since mammalian 
GnRH receptors lack a cytoplasmic tail and Serffhr-rich regions in their intracellular 
loops, alternative motifs or residues must determine its agonist-promoted 
internalization. Amino acid residues occurring three regions of the GnRH receptor 
have been implicated in its internalization. 
a) The highly conserved DRYXXV/IXXPL (DRSLAfTQPL in the mouse GnRH 
receptor, see Figure 5) sequence of the second intracellular loop of GPCRs has 
been shown to be critical in agonist-promoted internalization of the mouse GnRH 
receptor (Arora et al., 1995, 1997). The replacement of Ser140 (Figure 5) with Tyr 
resulted in a increased internalization rate, while replacement of Leu 147 (Figure 5) 
with either Ala or Asp markedly impaired internalization (Arora et al., 1995). 
b) Two residues in the conserved NP(X)2,3Y sequence of TM7 of GPCRs, Asp
318 and 
the aromatic moiety of Tyr322 (Figure 5) are also involved in the internalization of 
the GnRH receptor (Arora et al, 1996). 
c) Ala261 (Figure 5) in the third intracellular loop of the GnRH receptor was recently 
reported to be critical for its agonist-promoted internalization (Myburgh et al., 
1998). 
1.4.3 Desensitization of the GnRH receptor 
It is well established that pulsatile GnRH stimulation is necessary to produce a 
sustained output of gonadotropins from the mammalian pituitary in vivo, whereas 
continuous stimulation with GnRH agonist causes a cessation of gonadotropin 
secretion. This desensitization of the gonadotrope cell is of great interest as it is the 
basis for the clinical use of GnRH agonists to suppress the reproductive axis in a 
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number of human disorders (Millar et al., 1987). The mechanisms involved in 
desensitization of the gonadotrope have not been elucidated, and could in principle, 
operate at several levels including the GnRH receptor, G proteins, effector systems, 
gonadotropin synthesis and exocytosis. 
As discussed in Section 1.2, phosphorylation of Ser!Thr residues within the 
cytoplasmic tail of a number of GPCRs influences their desensitization. The lack of a 
cytoplasmic C-terminal tail in mammalian GnRH receptors has prompted several 
investigations into GnRH receptor desensitization (Davidson et al., 1994; McArdle et 
al., 1995, 1996, Anderson et al., 1995, Willars et al., 1998). It has now been shown 
by several groups that the mammalian GnRH receptor itself does not undergo rapid 
homologous desensitization, suggesting that desensitization to GnRH occurs at a 
level beyond both the receptor and phospholipase C activation. When M3 
muscarinic and GnRH receptors, both of which are coupled to phospholipase C, 
were co-expressed in aT3-1 cells and challenged with their respective agonists, only 
M3 muscarinic receptors underwent rapid desensitization (Willars et al., 1998), 
despite expression in the same cell background. This study demonstrates PLC-
coupled GPCRs can undergo rapid desensitization in the aT3-1 cell line, and that 
the desensitization profiles are receptor-specific rather than cell-specific. 
The GnRH receptor does contain consensus PKC phosphorylation sites (Tsutsumi et 
al., 1992) which could mediate heterologous desensitization, and phorbol ester was 
shown to attenuate GnRH-stimulated IP production (Davidson et al., 1994 ). 
However, IP production stimulated by direct activation of Gq111 using GTPyS in 
permeabilized cells was also inhibited by phorbol ester, suggesting that the site of 
action of PKC on GnRH action lies distal to the GnRH receptor (Davidson et al., 
1994). 
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McArdle et al. (1996) have demonstrated a novel form of desensitization to GnRH 
that is mediated at the level of mobilization of Ca2• from intracellular pools, rather 
than an uncoupling of the receptor from its proximate effector system. A possible 
new mode of GnRH-induced desensitization, which is a brief pause (of about 10 min) 
in LH secretion at 40-50 min associated with a decrease in cell surface GnRH 
receptor binding sites, has been demonstrated by Cassina et al. (1997). 
GnRH is known to downregulate GnRH receptors in pituitary cells by a number of 
mechanisms including reduction of receptor synthesis subsequent to a decrease in 
receptor mRNA levels (Mason et al., 1994), receptor degradation and endocytosis of 
the agonist-receptor complex (Stojilkovic et al., 1994). A recent study in which the 
cytoplasmic C-terminal tail of the catfish GnRH receptor was added to the C-
terminus of the rat GnRH receptor, reported enhanced rat receptor downregulation 
when compared with the wild type rat GnRH receptor (Lin et al., 1998). 
A potential role for GRKs and ~-arrestins in the desensitization of the mammalian 
GnRH receptor was demonstrated in a recent study (Neill et al., 1998). Co-
expression of GRK2 plus ~-arrestin-2 suppressed GnRH-stimulated IP3 production, 
with GRK3 plus ~-arrestin-2 producing similar results. This is particularly interesting, 
as GRK phosphorylation sites in other GPCRs are usually located in the cytoplasmic 
C-terminal tail, which is absent in the mammalian GnRH receptor. Endogenous 
GRK2/3 and ~-arrestin-1/2 expression was demonstrated in the rat anterior pituitary, 
suggesting the involvement of GRK-mediated regulation of the GnRH receptor in 
vivo. A member of a recently discovered family of proteins known as the regulators of 
G protein signaling (RGS3) has been reported to inhibit GnRH-stimulated IP3 
production, suggesting a role for RGS3 in GnRH receptor desensitization (Neill et 
al., 1997). 
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2 MATERIALS AND METHODS 
2.1 MATERIALS 
myo-[2-3H]inositol and Na1251 were obtained from The Radiochemical Centre 
(Amersham, Bucks., UK). All other chemicals were obtained from Sigma Chemical 
Co (St. Louis, MO), Merck (Darmstadt, Germany), or BDH (Poole, England). [D-
Lys6]GnRH was a gift from ·Dr. R. Roeske, Department of Biochemistry and 
Molecular Biology, Indiana University, School of Medicine, Indiana, USA. Antagonist 
26 was synthesized by Dr. David Coy, Tulane University School of Medicine, New 
Orleans, Louisiana, USA. mammalian GnRH, [D-Aia6]GnRH and [His5 , D-Tyr6]GnRH 
were synthesized by Mr. R.C. deL Milton from this laboratory. 
2.2 CELL CULTURE 
COS-1 cells were cultured in 15a cm2 tissue culture flasks (Corning, Cambridge, MA) 
in DMEM (Gibco, Grand Island, NY) containing 10% fetal calf serum (FCS)(Highveld 
Biological, Johannesburg, South Africa) in a 10% C02 atmosphere. For seeding of 
12-well culture plates (Corning), DMEM was aspirated and the cells dispersed by the 
addition of 5 ml trypsin (BDH). Cells were pelleted at 4aag, resuspended in 1 a ml 
DMEM/1 a% FCS and counted using a haemocytometer. 
For photoaffinity labeling studies, all experiments were performed on the aT3-1 
gonadotrope-derived cell line (Windle et al., 1990). Cells were cultured in 150 cm2 
tissue culture flasks in DMEM containing 10% FCS in a 1a% C02 atmosphere, and 
seeded into 35 mm (1 as cells/dish) or 1 aa mm (3 X 1 a6 cells/dish) dishes (Corning). 
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2.3 SITE-DIRECTED MUTAGENESIS 
2.3.1 Kunkel's Method 
The mouse GnRH receptor eDNA (Tsutsumi et al., 1992) was subcloned between 
the EcoR1 and Xho1 sites of the phagemid pcDNA1/Amp (Invitrogen, San Diego, 
CA). Oligonucleotide-directed mutagenesis was performed using the method of 
Kunkel et al. (1991 ). After passage through E. coli dufung·F' strain CJ236, uridine-
containing single-stranded DNA template was prepared using VCS M13 helper 
phage (Stratagene, La Jolla, CA). Mutant oligonucleotides (Table 5) were designed 
to encode the described amino acid substitutions as well as silent restriction sites to 
facilitate screening of mutant colonies. Oligonucleotides were phosphorylated with 
T 4 polynucleotide kinase (Promega, Madison, WI), hybridized with the template, and 
second strand synthesis was completed using T7 DNA polymerase (Biorad, 
Richmond, CA) and T4 ligase (Biorad). Products of the reaction were used to 
transform competent E.coli strain XU-blue cells. Plasmid DNA from ampicillin-
resistant colonies was prepared using NucleoSpin miniprep spin columns 
(Macherey-Nagal, Duren, Germany) according to manufacturer's instructions and 
digested with the appropriate restriction enzyme and clones showing the additional 
silent restriction site were sequenced, confirming the mutations. DNA was 
sequenced manually by the dideoxy chain termination method (Sanger et al., 1977) 
using the Sequenase 2.0 DNA sequencing kit (United States Biochemical 
Corporation) according to manufacturer's instructions or by an automatic sequencer 
(Modei373A, Applied Biosystems). 
2.3.2 PCR-based Site-Directed Mutagenesis 
The chicken GnRH receptor eDNA (Troskie et al., 1997) was subcloned between the 
Not1 and Xho1 sites of the phagemid pcDNA1/Amp. For truncation mutations, two 
primers, pcDNA1/Amp vector specific sense primer T7; 5'- AAT ACG ACT CAC -3' 
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and chicken GnRH receptor DNA specific antisense primer encoding a stop codon 
as well as a silent restriction site (Table 5); were used to amplify the chicken GnRH 
receptor eDNA, deleting the tail DNA sequence. The PCR product was digested with 
Not1 and Xho1, ligated into pcDNA1/Amp and used to transform competent E.coli 
strain XL 1-blue cells. Plasmid DNA from ampicillin-resistant colonies was 
sequenced, confirming the mutation. For point mutations, pcDNA1/Amp vector 
specific sense primer T7 and a chicken GnRH receptor DNA specific antisense 
primer (Table 5) and pcDNA1/Amp specific antisense primer SP6; 5'- ATT TAG GTG 
ACA CTA TAG -3' and a chicken GnRH receptor DNA specific sense primer (Table 
5) encoding the described amino acid substitutions as well as silent restriction sites, 
were used to amplify the chicken GnRH receptor eDNA The PCR products were 
digested with the appropriate enzymes, ligated into pcDNA 1/Amp and used to 
transform competent E. coli strain XL 1-blue cells. Plasmid DNA from ampicillin-
resistant colonies was digested with the appropriate restriction enzyme and clones 






















5'- GAT TAG CCT GGC AAG ATC TCT GGC CAT CA -3' 
5'- GAT TAG CCT GAA CCG CTC CC -5' 
5'- TGG TGA TTA GTC TAG ACA AAT CCC TGG CC -3' 
5'- TGG TGA TTA GTC TAG ACC AAT CCC TGG CC -3' 
5'- TGG TGA TTAGTC TAG ACC AAT CCC TGG CC -3' 
5'- GTC ACT CGA GTC AAA TGG CTG CTT CAA TGC CC -3' 
5'- ATT GCC CAG CAC GTG AGA CAC AAA CCC ATC TC -3' 
5'- GTC TCA CGT GCT GGG CAA TGG CTG CTT CAA TGC CC -3' 
5'- AAG GCT CGA GTT AGA TGG GTT TGT GTC TCA C -3' 
5'- AAG GCT CGA GTT ACT TCT CTG AGA CTG AGA T -3' 
5'- AAG GCT CGA GTT ACC CAT CCT TGG TGG TCT -3' 
5' GAG GTG GCA GCA GGT GGA TCC AA T GGG ACA -3' 
5'- AAG GCT CGA GTT AGC CAC CTG ATG TCA CCT -3' 
5'- GGC CAG GTG ACG TCA GGT GGC GCC AAT GGG -3' 
5'- TCA GGT GGA TCC AAT GGG GCA GCC GTT AAC -3' 
a The species of GnRH receptor is indicated by the first (lowercase) letter. m=mouse, h=human, and c=chicken. 
The mutation is indicated using the single-letter amino acid code. 
Example: mD138A refers to mutation of Asp138 to Ala in 
the mouse GnRH receptor 
All mutant GnRH receptor eDNA constructs listed in the above table were produced by the author as part of this 
thesis, except for the following: 
cS337stop, cS337 A 
hi143A, hi143L 
John Lopes, our laboratory 
Dr. Stuart Sealfon, Mount Sinai University, New York, USA 
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2.4 TRANSIENT TRANSFECTION 
Plasmid DNA for transfection was prepared using Nucleobond AX columns 
(Macherey-Nagal, DOren, Germany) according to the manufacturer's instructions. 
One day prior to transfection, COS-1 cells were seeded into 12-well culture plates at 
a density of 75,000 cells per well. On the day of transfection cells were washed once 
with serum-free DMEM containing 10 mM HEPES, pH 7.4 (HEPES/DMEM) and 
incubated with 1.0 IJg of plasmid DNA and 1.5 IJI of Lipofectin (Gibco) in 0.5 ml of 
serum-free OPTI-MEM (Gibco) medium. 6 hrs later, 0.5 ml of DMEM with 20% FCS 
was added, and cells were allowed to grow for 48 hrs before radioligand binding, 
inositol phosphate, or internalization assays were performed. 
2.5 MEASUREMENT OF RADIOLIGAND BINDING 
Radioligand binding and internalization studies of the mouse GnRH receptor were 
carried out using [D-Aia6]GnRH ([D-Aia6-N-Me-Leu7,Pro9-NEt]GnRH)(agonist) and 
Antagonist 26 ([Ac-D-p-CIPhe1,D-p-CIPhe2,D-Trp3,D-Lys6,D-Aia10-NH2]GnRH) 
radioligands. For chicken GnRH receptor internalization studies, the agonist [His5, 
D-Tyr6]GnRH was used as radioligand (Flanagan et al., 1998). The peptides were 
iodinated with Na1251 (Amersham) using chloramine T (Millar et al., 1984). Five 1-lg of 
peptide was dissolved in 40 1-11 of solution containing 0.5 M phosphate buffer (0.5 M 
NaH2P04 , pH 7.6). To this, 1 mCi (10 1-1l) Na
1251 was added, followed by the addition 
of 85 nmoles chloramine T in 1 0 1-11 phosphate buffer to start the iodination reaction. 
After 1 0 sec, 84 nmoles of sodium metabisulphite in 20 1-11 phosphate buffer was 
added to stop the iodination reaction. The resulting solution was purified on a 
reverse-phase C18 HPLC column, eluting with a 0-60% acetonitrile gradient in 0.01 
M ammonium acetate for [D-Aia6]GnRH (Figure 7) and 0-80% acetonitrile gradient in 
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0.01 M ammonium acetate for Antagonist 26 (Figure 8) and [His5, D-Tyr6]GnRH 
(Figure 9). 1.5 ml fractions were collected and peptide fraction stored at -70°C. 
Radioligand binding was measured in triplicate wells using intact, transiently 
transfected COS-1 cells in 12-well culture plates. Cells were washed for 5-1 0 min in 
ice-cold Buffer A (140 mM NaCI; 4 mM KCI; 20 mM HEPES, pH 7.4; 8 mM D-
glucose) containing 1 mM CaCI2 and 1 mM MgCb, then incubated at ooc (on ice) in 
0.5 ml of the same buffer containing 105 cpm radioligand per well (approx. 50 pM) 
and varying concentrations of the appropriate unlabeled peptide for 3 hrs, followed 
by 5 rapid washes in ice-cold Buffer A containing 1 mM CaCb , 1 mM MgCb and 
0.5% BSA (fatty acid free, Pentex fraction V, Miles Laboratories). Cells were 
solubilized in 0.5 ml of 0.1 N NaOH and radioactivity counted in a y counter (RIAstar, 
Packard). Unless otherwise stated, non-specific binding was determined in parallel 
using untransfected COS-1 cells, and was subtracted at each dilution. 
2.6 MEASUREMENT OF INOSITOL PHOSPHATE PRODUCTION 
24 hrs after transfection, cells were labeled overnight with 2 ~Cilml myo-[2-
3H]inositol (Amersham) in 0.25 ml/well Medium 199 (Gibco) containing 5% FCS, 
washed twice for 5 min in Buffer A containing 1 mM CaCb and 1 mM MgCb at 37°C, 
then stimulated with GnRH as required, in Buffer A containing 1 mM CaCb , 1 mM 
MgCb and 10 mM LiCI for 1 hr at 37°C with gentle agitation. Incubations were 
stopped after 1 hr with 0.5 ml perchloric acid (PCA) stopping solution (5 mM EDTA, 5 
mM DTPA, and 3.6% PCA (v/v)) and 50 ~I 2 mM phytic acid, neutralized with KOH, 
and total inositol phosphates chromatographed on Dowex 50X8-200 (Sigma) ion 
exchange columns, eluted with 3 ml 1 M ammonium formate; 0.1 M formic acid, and 
radioactivity determined (Davidson et al., 1990). 
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2.7 MEASUREMENT OF RECEPTOR INTERNALIZATION 
2. 7.1 Acid-Wash Method 
Internalization of GnRM receptors was measured by a modification of the acid-wash 
method of Hazum et al. (1983a). Transfected COS-1 cells in 12-well culture plates 
were washed once with ice-cold HEPES/DMEM, then incubated at ooc (on ice) in 
HEPES/DMEM with 105 cpm (approx. 50 pM) 1251-[D-Aia6]GnRH or 1251-[His5, D-
Tyr6]GnRH per well for 3 hrs and 5 hrs respectively. This pre-binding step was 
included to allow radioligand binding to reach equilibrium, under conditions where no 
internalization takes place. Cells were then warmed to 3rC in the original medium, 
and radioligand internalization was stopped after varying periods of time by placing 
the cells at ooc and rapidly washing twice with ice-cold phosphate-buffered saline 
(PBS). Acid-sensitive bound radioligand, representing cell surface-bound label, was 
removed by the addition of 1 ml ice-cold acid solution (150 mM NaCI, 50 mM acetic 
acid, pH 2.8) for 10 min. After removal of the acid wash, cells were solubilized with 1 
ml of 1 N NaOH to determine acid-resistant (internalized) radioligand content. Both 
acid-sensitive and -resistant fractions were counted. Non-specific binding was 
determined in parallel using untransfected COS-1 cells, and was subtracted at each 
time-point. Radioligand internalization was expressed as percent of total cell-
associated label (cell surface-bound plus acid-resistant) at each time-point (see 
Equation 1 ). In all % INTERNALIZATION plots, the % internalization at t = 0 was 
subtracted from the % internalization values at the remaining time-points, so that all 
curves begin at 0% internalization at t = 0. 
Equation 1: 
% internalization = _________________ a_c_id_-r_e_s_is_ta_n_t_c~p_m __________________ x 100 
acid sensitive cpm + acid-resistant cpm 
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2.7.2 Development of the 3, 3'-Diaminobenzidene cross-linking method for 
measuring GnRH receptor internalization 
Internalization of GnRH receptors was also measured by a modification of the 
horseradish peroxidase (HRP)-mediated 3, 3'-diaminob~nzidine (DAB) cross-linking 
method described by Thilo et al. (1995). In this method, transfected COS-1 cells are 
allowed to internalize radioligand in the presence of HRP for varying periods. 
Internalization is stopped by washing the cells on ice. Extracellular HRP is also 
removed during these washes. The cells are then incubated on ice in the presence 
of DAB, which diffuses into intracellular compartments containing internalized 
radioligand and HRP. The enzymatic activity of HRP polymerizes DAB in endosomes 
with consequent cross-linking of endosomal content proteins (including radioligand-
GnRH receptor complexes) to the DAB polymer. The cells are then solubilized in 
detergent, and the detergent insoluble cross-linked polymer (representing 
internalized radioligand-receptor complex) separated from soluble radioactivity 
(representing cell surface radioligand-receptor complex) by centrifugation. The 
radioactivity in the two fractions is determined, and the insoluble fraction expressed 
as% of total (soluble+ insoluble) radioactivity. 
Transfected COS-1 cells in 12-well culture plates (Costar) were placed at ooc (on 
ice), washed once with ice-cold HEPES/DMEM and then incubated at ooc in 
HEPES/DMEM containing 1 mg/ml HRP (Sigma) with 1251-[D-Aia6]GnRH for 3 hrs. 
Cells were then warmed to 3rC for varying periods of time. Internalization was 
stopped by placing the cells at ooc and HRP removed by washing twice with ice-cold 
PBS. Cells were then incubated for 30 min at ooc in the dark with HEPES/DMEM 
containing 0.45 mg/ml DAB (Sigma) and 50 mM ascorbic acid (Merck), pH 7.0. 
Ascorbic acid was added to prevent DAB cross-linking of cell surface components 
due to residual plasma-membrane-associated HRP (Stoorvogel et al.,1996). 
Hydrogen peroxide was added to a final concentration of 0.005% (v/v) and cells 
were incubated for a further 30 min at room temperature in the dark. Cells were then 
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solubilized in 1% (v/v) Triton X-1 00 and insoluble material was pelleted by 
centrifugation at 1 O,OOOg for 10 min. Radioactivity in the supernatant and pellet, 
representing cell surface and, internalized radioligand respectively, were counted, 
and internalized radioligand was expressed as a percentage of total bound label at 
each time-point. In all % INTERNALIZATION plots, the% internalization at t = 0 was 
subtracted from the % internalization values at the remaining time-points, so that all 
curves begin at 0% internalization at t = 0. 
As controls, samples were kept at ooc in the presence of HRP (no internalization), or 
H202 or DAB was omitted. In all cases, control solubility of radioligand in Triton X-
100 was between 90 and 95%. Non-specific binding was determined in parallel using 
untransfected COS-1 cells, and was subtracted at each time-point. 
2.8 PHOTOAFFINITY LABELING 
2.8.1 Labeling procedure 
The photoreactive GnRH analog, [N-azidobenzoyi-D-Lys6]GnRH was synthesized by 
Dr. Daniel Assefa in our laboratory according to Hazum (1981a,b). Five ~g of the 
photoreactive analog was iodinated using chloramine T as described in Section 2.5 
and purified on a reverse-phase C18 HPLC column, eluting as a single radioactive 
peak with a 0-60% acetonitrile gradient. All the procedures prior to UV irradiation 
were performed in minimal lighting, conditions which had been shown not to cause 
photolysis of the photoreactive ligand. The iodinated ligand was stored at -70°C. 
Intact aT3-1 cells were incubated with 0.5 ml (35 mm dishes) or 1.2 ml (1 00 mm 
dishes) Buffer A containing 1 mM CaCI2, 1 mM MgCI2, and 10
6 cpm (35 mm dishes) 
or 5 X 106 cpm (100 mm dishes) of 1251-[N-azidobenzoyi-D-Lys6]GnRH at 4°C for 90 
min. Buffer A consisted of 140 mM NaCI; 4 mM KCI; 20 mM HEPES, pH 7.4; 8 mM 
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0-glucose. The dishes (on ice) were irradiated for 90 sec at a distance of 2 em from 
a Spectroline TR-312A UV transilluminator. 
2.8.2 Determination of the in vitro stability of the 1251-[N-azidobenzoyi-D-
Lys6]GnRH cross-link to the GnRH receptor 
Photoaffinity labeled aT3-1 cells in 100 mm dishes were detached in ice-cold 
binding buffer (10 mM HEPES, 1 mM EDTA, pH 7.4), homogenized with 15 strokes 
of a glass Dounce homogenizer, and centrifuged for 10 min at 400g to pellet nuclei. 
The supernatant was centrifuged at 1 OOOOg for 30 min at 4°C, and the membrane 
pellet resuspended by drawing it through a fine needle in 0.25 ml of binding buffer 
per dish of cells. Following further manipulations (see Figure legends), Triton X-1 00 
was added from a 10% stock solution to a final concentration of 1% and membranes 
solubilized by incubating on ice for 30 min. Unsolubilized material was removed by 
centrifugation at 1 OOOOg for 10 min, and the supernatant was mixed with SDS 
sample buffer and an aliquot electrophoresed for 18 hrs at room temperature on 1 0% 
80S-polyacrylamide gels (Schagger and von Jagow, 1987). Gels were stained with 
Coomassie Blue (0.1% Coomassie Brilliant Blue; 40% methanol; 10% acetic acid) 
and autoradiographed using Kodak X-OMAT autoradiography film by exposing for 2-
14 days at -70°C. Molecular masses of labeled bands were determined by graphical 
interpolation from plots of R, vs. log molecular weight for standard proteins. 
2.8.3 Intracellular degradation of the 1261-[N-azidobenzoyi-D-LysiGnRH cross-
linked GnRH receptor 
Immediately following UV irradiation, photoaffinity labeled aT3-1 cells in 35 mm 
dishes were washed twice with ice-cold PBS/1% BSA followed by one wash with ice-
cold PBS. 1.5 ml HEPES/DMEM was added to all dishes which were then incubated 
at 37°C for the indicated times. At each time-point the dishes were transferred onto 
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ice, the medium collected in tubes and counted in a y-counter. The cells were 
detached in ice-cold binding buffer (10 mM HEPES; 1 mM EDTA, pH 7.4), 
transferred to ·1.5 ml eppendorff tubes, and pelleted at 400g for 10 min. The pellet 
was solubilized in 1 X RIPA buffer (150 mM NaCI; 50 mM Tris, pH 8.0; 5 mM EDTA; 
1% Nonidet P-40; 0.5% sodium deoxycholate; 0.1% SDS) and unsolubilized material . . 
removed by centrifugation at 1 OOOOg for 10 min. The supernatant was mixed with 
SDS sample buffer and electrophoresed as described above. 
2.9 DATA PRESENTATION 
Data points and error bars represent the SEM of duplicate or triplicate 
determinations. The absence of error bars indicates that the error was smaller than 
the dimensions of the symbol. Peptide concentrations required to stimulate half-
maximal IP production (EC50) were estimated by non-linear regression to equation 2, 
where IP is the IP response to concentration A of agonist, and IPmax is the maximal 
response, using Prism (Graphpad) software. Peptide concentrations required to half-
maximally inhibit binding of radioligands (ICso values) were estimated by non-linear 
regression to the single-site binding equation with unitary Hill coefficient (see 
Equation 3). K values were obtained by correction of the IC50 values by the method 
of Munson and Rodbard (1988). Internalization data were fitted by non-linear 
regression to the single component exponential equation (see Equation 4, and 
Section 2.9 .. 1 below for derivation), where Y max is the maximal % internalization, K 
the rate constant, and t the time. 
Equation 2: 
IP= IPmax 
(1 + EC50 /A) 
Equation 3: 
Y = Y min + (Y max - Y min) 
(1 + 1Q(X-IogiC50)) 
Equation 4: 
F = F max(1 - e-A.t) 
X= log(peptide concentration) 
2.9.1 Derivation of a simple model for receptor internalization (Equation 4) 
Let: 
Model of receptor trafficking 
plasma 
membrane 
s = number of surface receptors 
i =number of internalized receptors 
r1 =rate of delivery of new receptors to the surface 
r2 =rate of internalization of receptors 
r3 =rate of recycling of receptors 
r 4 = rate of degradation of receptors 
Assumptions of the model 
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1. We treat only the simple case where r2, r3 >> r1 , r4, and consider only the larger 
receptor fluxes r2 and r3 
2. The total number of receptors is assumed to be constant, T = s + i 
3. We assume first-order kinetics for internalization and recycling rates, 
i.e. r2 = k2s 
r3 = ~i 
Since r4 is neglected, we may write the differential equation 
Let the fraction of inte-rnalized receptors, F = iff 
Then, 
dF/dt = d(iff) I dt = 1ff(dildt) = k2 ~ F(k2 + ~) ,from which we obtain, 
dF/dt = (k2 + ~)[k2/ (k2 + ~) - F] 
which is of the form dY/dt = b(a- Y), having the integral Y = a(1 - e·bt) 
Therefore, integrating eqn. 5 yields, 
At steady state ( t = oo ), the internalized fraction F is maximal, so that 
Eqn. 6 may then be written 
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(eqn .. 5) 
(eqn. 6) 
(eqn. 4) 
If experimental receptor internalization data is fitted to eqn. 4, the rate constants k2 
(internalization rate constant) and k3 (recycling rate constant) are obtained from 
the relations, 
~ = A.(1 - Fmax) 
If Fmax is expressed as% of total cell-associated receptors, then 






3 ROLES OF THE HIGHLY CONSERVED Asp138-Arg139 PAIR IN ACTIVATION. 
COUPLING, AND AGONIST-PROMOTED INTERNALIZATION OF THE 
GnRH RECEPTOR 
3.1 RESULTS 
To investigate the role of Asp138 and Arg139, the following GnRH receptor mutations 
were constructed: mD138N, mD138A, mR139Q, mR139K, and mR139H. Bmax, Kt 
and K values for the mD138N and mR139Q receptors are given in Table 6. 
3.1.1 The mR139Q mutation 
The mR139Q receptor displayed 8-fold lower binding affinities for GnRH and 
Antagonist 26, and a 2-fold lower affinity for the superagonist [D-Aia6]GnRH (Table 
6, Figures 10-12). However, this mutant receptor exhibited increased binding (Bo) of 
both GnRH agonist and antagonist radioligands, an unusual combination of findings 
which implies increased receptor number. Calculated receptor numbers (Bmax) using 
Kt values derived from homologous displacement binding experiments revealed that 
the mR139Q GnRH receptor was overexpressed by 6- to 1 0-fold, irrespective of 
whether binding was measured using agonist or antagonist radioligand (Table 6). As 
binding was measured in intact cells, the values for receptor numbers represent 
receptors expressed on the cell surface, and not intracellular pools of receptors. 
Although the mR139Q GnRH receptor was expressed at higher levels than wild type, 
maximal GnRH-stimulated IP production in the mR139Q GnRH receptor-expressing 
cells was only 68±7.0% of wild type (Figure 13 and Table 7). In addition, the dose-
response curve for IP production mediated by the mR139Q GnRH receptor was 
markedly shifted to the right, with a 150-fold higher EC50 than the wild type receptor 
(Figure 13 and Table 7). Although part of this increase in EC50 can beattributed to 
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the 8-fold decrease in affinity of the mutant receptor for GnRH (Table 6), it was 
evident that the mutant receptor has, in addition, a markedly lower coupling 
efficiency to its effector system. 
TABLE 6 AGONIST AND ANTAGONIST BINDING PARAMETERS FOR MOUSE 
WILD TYPE AND MUTANT GnRH RECEPTORS 
Agonist binding 
























Values shown are mean ± S. E. M. of the number of independent experiments shown in parentheses. 
a Total receptor number (Bmax) determined utilizing agonist radioligand 1251-[D-Aia6]GnRH, calculated using K.J 
values derived by homologous displacement with unlabeled peptide. 
b Total receptor number (Bmax) determined utilizing antagonist radioligand 1251-Antagonist 26, calculated using K.J 
values derived by homologous displacement with unlabeled peptide. 
Since the maximal IP response (IPmax) is dependent on receptor number as well as 
coupling efficiency, and potency (ECso) for second messenger production depends 
on both binding affinity (~) and receptor number (Bmax), a quantitative definition of 
coupling efficiency is required to compare receptor mutants which also have altered 
levels of expression and/or agonist binding affinity. An operational quantitative 
measure of coupling efficiency (c) may be arbitrarily defined as 
73 
e=(IPmaxiBmax)/(ECso/Ki) and normalized to a value of E = 100% for the wild type 
receptor. Defined in this way, receptor mutants with impaired coupling are 
characterized by e values less than 100% (Ballesteros et al., 1998). The mR 139Q 
GnRH receptor had a coupling efficiency E = 6%, indicating severe uncoupling. 
TABLE 7 INOSITOL PHOSPHATE PRODUCTION PARAMETERS FOR MOUSE 
WILD TYPE AND MUTANT GnRH RECEPTORS 
-----------------~---------------------------------------------------------------------------------------------
Wild type 
Inositol phosphate production 
IPmax (% WT) 
EC50 (GnRH)(nM) 
Coupling efficiencl 












Values shown are mean± S.E.M. of the number of independent experiments shown in parentheses. 
a e is an arbitrary measure of coupling efficiency, defined as e = (IPmax I Bmax) I (ECso I K;}, normalized to a value 
of 100% for the wild type receptor (Ballesteros et al., 1998). The value given was calculated using the mean 
IPmax, K;, and ECso values for GnRH, and the mean Bmax value from binding experiments using agonist 
radioligand. 
3.1.2 The mD138N mutation 
The· mD138N GnRH receptor had essentially unchanged agonist and antagonist 
binding affinities, but its expression was decreased to 55% and 67% of wild type 
level, measured using agonist and antagonist radioligands respectively (Figures 10, 
11, and 12, Table 6). GnRH-stimulated IP production parameters were similar to wild 
type, indicating that the mD138N GnRH receptor is well coupled to its effector 
system (Figure 13, Table 7). Furthermore, the fact that the mD138N GnRH receptor 
showed IPmax and EC50 values similar to the wild type receptor, despite its reduced 
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expression level, indicated that the m0138N mutation enhanced the coupling 
efficiency of the receptor, as reflected in its increased coupling efficiency (a) value of 
310% (Table 7). 
3.1_.3 The mR139K, mR139H, and mD138A mutations 
The mR139K, mR139H, and m0138A mutations completely abolished agonist 
(Figure 14) and antagonist (Figure 15) binding, as well as IP production (Figure 16), 
indicating either gross misfolding, or failure of expression of these mutant receptors. 
3.1.4 Temperature modulation of agonist binding 
Some GPCRs, including the a1- and ~radrenergic receptors exhibit a low-
temperature-induced increase in agonist binding affinity, which has been suggested 
to be similar to the transition from a resting low-affinity state (R) to an activated high-
affinity state (R*) (Weiland et al., 1979; Schwarz et al., 1986a, b; Lynch et al., 1988) 
The wild type mouse GnRH receptor also showed temperature modulation of agonist' 
binding which was most clearly demonstrated by rapid dissociation of radioligand 
bound at 4°C upon shifting the receptor-ligand complex to 37°C. In Figure 17, wild 
type mouse GnRH receptors were allowed to bind radioligand at either 4°C or 37°C, 
followed by a shift to the opposite temperature for the same incubation time. At 
various time-points during these incubation periods the total amount of radioligand 
bound was measured. Rapid dissociation of radioligand bound at 4°C was observed 
following the shift to 3]CC (Figure 17). In addition, a shift from 37°C to 4°C produced 
the opposite result, i.e. increased binding of agonist (Figure 17). 
Since Arg3·50 was essential for coupling, it was of interest to determine whether this 
residue had an essential role in the transition between the high and low agonist 
affinity states induced by low temperature. Put another way, since the mR 1390 
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mutant receptor was poorly coupled (see Section 3.1.1) it was of interest to 
determine whether it could achieve the high agonist affinity (R*) state induced by low 
temperature. Figure 18 shows the dissociation of radio ligand bound at 4°C following 
a shift to 37°C, in the wild type GnRH receptor and in the m0138N and mR139Q 
mutant receptors. Both mutant receptors exhibited marked loss of ligand binding at 
the higher temperature, similar to the wild type receptor. 
3.1.5 Optimization of the acid-wash method for measuring GnRH receptor 
internalization 
The time-course of binding of 1251-[D-Aia6]GnRH to wild type mouse GnRH receptors 
(Figure 19) shows that binding equilibrium was approached after 3 hrs at ooc, when 
105 cpm 1251-[D-Aia6]GnRH is added per well. A 3 hr pre-incubation at ooc was 
therefore used for further internalization studies. 
The length and number of acid washes required to maximally remove surface-bound 
1251-[D-Aia6]GnRH (acid-sensitive fraction) was determined (Figure 20). One 10 min 
acid-wash was found to remove more than 90% of surface-bound radioligand, while 
two 1 0 min or one 30 min acid-wash did not increase this fraction. One 1 0 min acid-
wash was therefore used for further internalization studies. 
3.1.6 Optimization of the 3, 3'-Diaminobenzidene cross-linking. method for 
measuring GnRH receptor internalization 
The time-course of binding of 1251-Antagonist 26 to wild type mouse GnRH receptors 
(Figure 21) shows that binding equilibrium was not reached after 4 hrs at 0°C. 
When the acid-wash method was used to measure internalization of 1251-Antagonist 
26, it was found that the acid solution was unable to remove more than 50% of the 
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surface-bound radioligand (Figure 22). For this reason it was necessary to develop 
the DAB cross-linking method for studying the internalization of antagonist-occupied 
GnRH receptors. 
3.1. 7 Internalization of antagonist-occupied mouse wild type Gn~H receptors 
The DAB cross-linking method was used to evaluate the internalization of the 
antagonist radioligand, 1251-Antagonist 26 (Figure 23 left) by the wild type mouse 
GnRH receptor. Surface binding increased linearly with time and did not plateau 
during the period measured (Figure 23, left top panel). This slow on-rate is also 
reflected in the time-course of binding of 1251-Antagonist 26 at 4°C (Figure 21 ). The 
fraction of bound antagonist radioligand that became internalized in 90 min was very 
small (Figure 23, left bottom panel). In contrast, more than 30% of agonist 
radioligand bound to receptors was internalized in 90 min (Figure 23 right panels). 
3.1.8 Validation of the acid-wash method for measuring agonist-occupied 
GnRH receptor internalization 
Untransfected cells were used as a control to determine whether the internalization 
of agonist radioligand in transfected COS-1 cells was entirely receptor-mediated, or 
whether non-specific bulk-phase endocytosis contributed to internalization. 
As shown in Figure 24, acid-resistant ('internalized') agonist radioligand remained 
constant with time in untransfected cells, indicating that bulk-phase endocytosis 
does not contribute significantly to internalization of radioligand using this protocol. 
In all subsequent experiments, non-specific acid-resistant and acid-sensitive 
radioactivity was determined at each time-point in untransfected COS-1 cells in 
parallel and subtracted from the data. A component of the non-specifically surface-
bound radioligand decreased after warming to 37°C. 
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3.1.9 Agonist-promoted internalization of the mD138N and mR139Q mutant 
GnRH receptors 
T~e role of Arg 139 in agonist-promoted internalization of the GnRH receptor was 
evaluated by determining the kinetics of receptor-mediated 1251-[D-Aia6]GnRH 
internalization using both the acid-wash method and DAB cross-linking method 
(Figures 25 and 26). Both methods gave similar results. After 90 min incubation at 
3rC, 34-40% of bound label was internalized by the wild type receptor, while the 
mR139Q mutant receptor exhibited markedly decreased internalization (38-52% of 
wild type level, Table 8). The m0138N mutant consistently showed slightly enhanced 
internalization (117-121% of wild type level, Table 8). 
The % internalization data were fitted to equation 4 (Section 2.9.1) by non-linear 
regression, which yielded values for Fmax and A.. The internalization rate constants 
(k2) and the recycling rate constants (~) were derived using equations 9 and 1 0 
(Section 2.9.1 ). 
The mR139Q receptor displayed a decreased internalization rate constant (k2) and 
increased recycling rate constant(~) (Table 8). Both rate constants for the m0138N 
receptor were similar to wild type (Table 8). 
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TABLE 8 AGONIST-PROMOTED INTERNALIZATION PARAMETERS FOR 
MOUSE WILD TYPE AND MUTANT GnRH RECEPTORS 
Wild type mD138N mR139Q 
Acid-wash method 
o/oWTa 100 117±9.9 (3) 51.5±2.3 (3) 
FMAX 
b 39.8±3.2 46.4±4.0 20.5±4.0 
'A.c 0.031±0.006 0.037±0.009 0.045±0.006 
k2d 1.24 1.69 0.92 
k3e 1.88 1.95 3.57 
DAB cross-linking method 
%~ 100 121±5.7 (3) 37.8±3.0 (3) 
FMAX 
b 34.5±1.8 41.9±2.0 13.3±0.6 
'A.c 0.042±0.006 0.043±0.006 0.045±0.006 
k2d 1.44 1.78 0.60 
kJe 2.74 2.47 3.89 
a Internalization of 1251-[D-Aia6]GnRH after 90 min at 37"C, normalized to % of wild type. Internalization was 
measured using the both acid-wash and DAB cross-linking methods (see Section 2.7). Values shown are mean 
± S.E.M. of the number of independent experiments shown in parentheses. 
b FMAX , the extrapolated maximal % internalization at equilibrium, was determined by curve fitting. 
c A., the time constant, determined by curve fitting. 
d k2, the internalization rate constant in %.min·1, was calculated from equation 9, Section 2.9.1 
e kJ. the recycling rate constant in %.min·1, was calculated from equation 10, Section 2.9.1 
3.1.1 0 The role of PKC activation in agonist-promoted internalization 
Since the mR139Q receptor was uncoupled, its defective internalization could have 
resulted "from its failure to activate signaling pathways. To determine whether the 
impaired internalization of the mR139Q GnRH receptor was due to its inability to 
activate phospholipase C and hence PKC, cells expressing wild type and mR139Q 
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GnRH receptors were pre-incubated with the phorbol ester PMA before 
determination of radioligand internalization. PMA increased wild type receptor 
internalization at 90 min from 33.3±2.2% to 39.0±1.8%, and increased mR139Q 
GnRH receptor internalization from 13.1 ±0. 7% to 20.6±1.6% (Figure 27). 
3.1.11 The requirement for an intact arginine-cage for agonist-promoted 
internalization 
The requirement for an intact Arg-cage (see Section 1.3.3.1) for efficient agonist-
promoted internalization was evaluated by determining the kinetics of receptor-
mediated 1251-[D-Aia6]GnRH internalization by hi143A and hi143L mutant receptors. 
Figure 28 shows the time-course of internalization of 1251-[D-Aia6]GnRH in COS-1 
cells expressing wild type human GnRH receptor, hi143A and hi143L mutant GnRH 
receptors. After 90 min incubation at 3rC, the wild type receptor internalized 
25.3±1.7% of bound label, while the hi143A mutant receptor exhibited markedly 
decreased internalization (46.3±4.3% of wild type level). The hi143L mutant GnRH 
receptor showed a level of internalization similar to wild type (88.4±1.0% of wild type 
level). 
3.2 DISCUSSION 
3.2.1 Role of Arg 139 in coupling 
The arginine residue (Arg3'50) located at the interface between the third 
transmembrane domain and the cytoplasm is conserved in all members of the 
rhodopsin-like subgroup of GPCRs, and is nearly always preceded by an acidic 
residue (Asp or Glu). This (E)DRY motif has been proposed to play an essential role 
in the coupling of these receptors to G proteins (Franke et al., 1990, 1992; Ohyama 
et al., 1992; Min et al., 1993; Rosenthal et al., 1993; Benya et al., 1994; Zhu et al., 
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1994; Jones et al., 1995; Dhanwada et al., 1996). In the present study, the role of 
these residues, Asp138 and Arg139, in coupling and agonist-promoted internalization 
of the mouse GnRH receptor was investigated by mutating them to neutral amide 
residues. 
The mR139Q substitution resulted in decreased binding affinities for both GnRH 
agonist and antagonist, increased cell surface receptor number and a markedly 
increased ECso of GnRH for IP production. The mR139Q GnRH receptor was 
severely uncoupled since the IPmax in mR139Q transfected cells was lower than for 
wild type receptor, notwithstanding the fact that 6- to 1 0-fold more mR139Q mutant 
receptors were expressed on the cell surface. In addition the ECso for IP production 
was increased 20-fold more than expected from the effect of the mutation on GnRH 
binding affinity. This uncoupling is reflected in the lowe (coupling efficiency) value of 
6% (Table 7). 
The ECso of GnRH for IP production by the mR139Q GnRH receptor (65.2 nM) was 
greater than the measured Kt (8.88 nM). This might appear to be inconsistent with 
receptor activation theory, which predicts that ECso will always be less than or equal 
to Kt depending on the degree of receptor reserve (Loeb and Strickland, 1987; 
Kenakin, 1993). This discrepancy most likely results from differences in the 
conditions of the experiments designed to measure Kt and EC50. Firstly, Kt was 
measured under near-equilibrium binding conditions, whereas the EC50 reflects IP 
accumulation over a time period during the early part of which GnRH binding is far 
from equilibrium. Secondly, Kt and EC50 were measured at 4°C and 3rC 
respectively, and a lower temperature is known to promote formation of the high 
agonist affinity state in some GPCRs including the GnRH receptor (Schwarz et al., 
1986; this thesis Section 3.1.4 ). Both of these factors would tend to increase the 
measured EC50 relative to the Kt for any given agonist. 
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Previous mutational analyses of Arg3·50 in other receptors have implicated this 
residue in the coupling of a number of GPCRs to their respective effector systems. 
Studies with the m1 muscarinic receptor reported the effects of mutating Arg3·50 to a 
series of residues including Lys, Ala, Leu, Glu, Asn, and Gin (Zhu et al., 1994; Jones 
et al., 1995). Mutants of the m1 muscarinic receptor in which the positive charge of 
Arg3·50 was replaced with neutral polar, non-polar, or negatively-charged residues 
showed normal antagonist and decreased agonist binding affinities, and expression 
levels similar to wild type. However, these mutant receptors exhibited strongly 
disrupted IP production (i.e. uncoupling). The charge-conserving mutation R3.50K of 
the m1 muscarinic receptor showed normal antagonist and increased agonist 
binding affinities with the normal maximal IP response being preserved, although 
agonist potency to stimulate IP production was decreased by 6-fold compared with 
wild type, indicating a moderate degree of uncoupling (Jones et al., 1995). 
In rhodopsin, mutation of Arg3·50 to Gly, Leu and Trp resulted in total uncoupling, 
while the R3.50K and R3.50Q mutants retained a low level of coupling (Franke et al., 
1992; Min et al., 1993). In addition, reversal of the motif (ER~RE) caused 
impairment of coupling, while substitution of both residues with Ala (ER~AA) 
resulted in complete uncoupling (Franke et al., 1990, 1992). The R3.50G mutant of 
the gastrin-releasing peptide receptor displayed a decreased agonist binding affinity 
and was unable to stimulate IP production (Benya et al., 1994). The R3.50H 
substitution in the lutropin/choriogonadotropin receptor resulted in nqrmal agonist 
binding, but decreased cAMP response (Dhanwada et al., 1996), and similar findings 
were reported for the R3.50H mutation in the V2 vasopressin receptor (Rosenthal et 
, al., 1993). Mutation of the DRY motif to GGA in the AT1A receptor preserved normal 
agonist binding affinity but abolished IP production (Ohyama et al., 1992). 
In a study carried out simultaneously with work reported in this thesis, Arora et al. 
(1997) reported that the mR139Q mutant of the mouse GnRH receptor displayed a 
50% reduction in expression at the cell surface, in addition to an impaired ability to 
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stimulate IP production. This is in contrast to the results reported in this thesis where 
an increased expression level (6- to 1 0-fold) at the cell surface was observed. No 
adequate explanation for this inconsistency can be offered at the present time. 
However, Arora et al. (1997) used the COS-7 cell line for the transient expression of 
their receptors, while the COS-1 cell line was used in the present studies. The . . 
possibility that the COS-1 and COS-7 clones could synthesize or degrade mR139Q 
receptors at different rates cannot not be excluded, although this seems unlikely. 
Taken together, these results indicate that the positive charge of Arg3·50 is critical for 
receptor-G protein coupling. All GPCR mutations resulting in a loss of this charge 
exhibited impaired coupling and the present findings on the GnRH receptor are 
consistent with this. Neither a positive charge nor a polar residue at this locus is 
universally required for normal receptor folding and cell surface expression. 
However, some GPCRs, including the GnRH receptor, show complete loss of ligand 
binding when a non-polar residue is substituted for Arg3·50, indicating either gross 
misfolding or blocked cell surface expression. The results reported here for the 
GnRH receptor differ from those for the m1 muscarinic receptor and rhodopsin, in 
that even the conservative R3.50K substitution resulted in total abolition of agonist 
and antagonist binding in the GnRH receptor. Therefore, it could not be determined 
whether K could substitute for Arg3·50 in coupling in the GnRH receptor. The severely 
impaired coupling reported in the rhodopsin R3.50K mutant (Min et al., 1993) 
suggests that a positive charge at this position is not the only requirement for 
coupling, and that Arg3·50 participates in other hydrogen bonding or steric 
interactions which K cannot mimic. A clearer understanding of the role of this residue 
in receptor-G protein coupling will require that the effects of the R3.50K mutation be 
characterized in other members of the rhodopsin-like GPCRs. 
The severe uncoupling of the mR139Q GnRH receptor suggests that Arg3·50 
participates in the change in receptor conformation (R~R*) which accompanies 
receptor activation. It raises the question whether this mutant is uncoupled because 
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it fails to adopt the R* conformation, or whether it can adopt an R*-like conformation 
(as far as the binding pocket is concerned) but nevertheless fails to activate the G 
protein. Since the R* conformation has a high agonist affinity (De lean et al., 1980), 
the decreased agonist affinity of the mR139Q GnRH receptor observed (Figures 10 
and 11) would be consistent with a failure to adopt an R* conformation. However, the 
mR139Q GnRH receptor also showed lower antagonist affinity than the wild type 
GnRH receptor (Figure 9), which would not be predicted if the decrease in agonist 
affinity was due to an inability to assume an R*-like conformation. 
Relevant to this is the finding that, in the mouse GnRH receptor, low temperature 
induces a receptor state which has high agonist affinity (and therefore resembles R*, 
at least as far as the binding pocket is concerned), as has been previously shown in 
some other GPCRs (Weiland et al., 1979; Schwarz et al., 1986a, b; Lynch et al., 
1988). It was therefore of interest to determine whether the mR139Q GnRH receptor 
showed the same temperature modulation of agonist affinity. In fact, the mR139Q .. 
GnRH receptor did show temperature modulation of agonist binding, similar to wild 
type GnRH receptor (Figure 15). This result indicates that while Arg3·50 is critical for 
coupling, its side-chain interactions are not required for the conformational change 
towards a high agonist affinity state induced by low temperature. 
3.2.2 Role of Asp 138 in coupling 
Mutagenesis studies investigating the role of the highly conserved acidic residue 
Asp3.49/Giu3·49 have produced a spectrum of effects on coupling in different receptors, 
ranging from uncoupling to constitutive activation. In the J32-adrenergic and m1 
muscarinic receptors the D3.49N mutation preserved high affinity agonist binding, 
but significantly decreased or completely abolished activation of their effector 
systems (Fraser et al., 1988, 1989). Similarly, the E3.49D substitution in rhodopsin 
resulted in decreased Gt activation (Franke et al., 1992). In contrast, constitutive Gt 
activation was observed in the E3.49Q mutant rhodopsin (Sakmar et al., 1989), and 
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the D3.49A mutation of the a1s-adrenergic receptor also led to constitutive activation 
(Scheer et al., 1996). No effect on signal transduction was reported when Glu3·49 was 
mutated to Asp or Gin in the lutropin/choriogonadotropin receptor (Wang et al., 
1993). In the present study, the mD138N GnRH receptor showed· no evidence of 
increased basal activity, but had an increased ~lculated coupling efficiency (e = 
31 0%), suggesting that this mutation perturbs the GnRH receptor conformation 
equilibrium slightly towards the activated state. 
Arora et al. (1997) also reported decreased expression and an enhanced coupling 
efficiency for their mD138N mutant GnRH receptor. However, expression was 
decreased to 1/10th of the wild type receptor, in contrast to the 55-67% reduction 
reported in this thesis. As discussed above, this difference may be related to their 
use of COS-7 cells. In addition, their mD138N mutant GnRH receptor showed a 
higher rate of agonist-promoted internalization than wild type, consistent with the 
results presented here. 
3.2.3 Models for GPCR activation 
Because of its high degree of conservation, and its location at the membrane-
cytoplasm interface, Arg3·50 has been proposed to play a pivotal role in receptor 
activation (Oliveira et al., 1994; Scheer et al., 1996; Ballesteros et al., 1998). 
A number of highly conserved polar residues including, Asn1·50 of TM1, Asp2·50 of 
TM2, and Asn7·49 and Tyr7·53 of TM7 (Asn53, Asn87, Asp318 and Tyr322 in the mouse 
GnRH receptor) (see Figure 5), are believed to form a polar pocket near the cytosol, 
as has been highlighted by different modelling studies (Trumpp-Kallmeyer et al., 
1992; Oliveira et al., 1994, Scheer et al., 1996). The Arg-switch model of Oliveira et 
al. ( 1994) is shown in Figure 29a. This model proposes that Arg3·50 (Arg 139 in the 
mouse GnRH receptor), which is located near both the cytosol and the highly 
conserved polar pocket, has a 'switching' role which is expressed through two 
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alternative positions of its side-chain. In this model, the highly conserved Leu2.46, 
four residues away from Asp2·50 , is positioned to orient the Arg3·50 side-chain through 
hydrophobic interaction. When the Arg3·50 side-chain is in the polar pocket formed by 
Asn1·50, Asp2·50, Asn7.49 and Tyr7·53 the switch is off, while the switch is on when the 
side-chain is shifted toward the cytosol where it can bind and activate the G protein 
(Oliveira et al., 1994). 
The high degree of conservation of the acidic Glu/Asp3.49 in GPCRs could imply that 
protonation of this negatively charged side-chain is part of a mechanism for receptor 
activation. In the model of a 18-adrenergic receptor activation of Scheer et al., 1996 
(Figure 29b), it was suggested that the R (inactive) state is stabilized by the network 
of hydrogen-bonding interactions between Asn 1·50, Asp2·50, Asn7·49 and Tyr7·53 forming 
the· polar pocket, and Arg3·50 of the DRY sequence motif. This model of the a 18-
adrenergic receptor, suggests that protonation of Glu/Asp3.49 (Asp138 in the mouse 
GnRH receptor) disrupts the salt bridge, between Asp3.49 and Arg160 of the a 18-
adrenergic receptor on the C-terminal side of the second intracellular loop (at the 
bottom of TM4), which exists in the R state of the receptor. This disruption is 
predicted to induce helical movements which cause conformational changes in the 
second intracellular loop that force Arg3·50 out of the polar pocket, thus exposing 
several residues to the cytosol. These residues then achieve the correct 
configuration for the formation of a G protein docking and binding site i.e. the R* 
(active) state (Scheer et al., 1996). 
As discussed in Section 1.3.3.1, Ballesteros et al. ( 1998) have recently proposed the 
Arg-cage hypothesis, based on the GnRH receptor, as a model for GPCR activation. 
In particular, it is proposed that the inactive receptor conformation is stabilized by an 
ionic interaction between Glu/Asp3.49 and Arg3·50, and that the Glu/Asp3·49 becomes 
protonated upon receptor activation allowing the Arg3·50 side-chain to be released 
and to participate in G protein activation (Figure 29c). This 
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model of the GnRH receptor suggests that the conserved residues surrounding 
Arg3·50 act like a cage that affects the orientation of the Arg side-chain, and that a 
highly conserved f3-branched lie residue (lle3·54) in the a-helical turn following Arg3·50 
supports the orientation of the Arg3·50 side-chain that is required for efficient 
receptor-G protein interaction. The model also predicts that disruption of the cage 
will impair receptor function. Indeed, mutation of lle143<3·54> to Ala, which eliminates 
the branched side-chain, resulted in considerably impaired receptor-G protein 
coupling, providing experimental support for this Arg-cage hypothesis (Ballesteros et 
al., 1998). 
The present data are consistent with the above models of receptor activation for the 
GnRH receptor, since they predict that mutation of Arg3·50 will disrupt receptor-G 
protein coupling, as has been shown here for the GnRH receptor (discussed above). 
Furthermore, although there is no Arg residue on the C-terminal side of the second 
intracellular loop of the mouse GnRH receptor, to form a salt bridge with Asp138<3A9>, 
(as described above in the a1s-adrenergic receptor model between Arg160 and 
Asp3·49) there is a Lys residue (Lys154<4.40>, two residues away from the position of 
Arg160 in the a18-adrenergic receptor) which may satisfy this requirement. Previous 
mutagenesis studies of the GnRH receptor are also consistent with the models of 
Oliveira et al. and Scheer et al. When Asn87<2·50> of the GnRH receptor was mutated 
to Asp, impaired ligand binding and signal transduction was observed (Zhou et al., 
1994). Mutation of Asp2·50 of a number of GPCRs had been shown to disrupt signal 
transduction (reviewed in Savarese and Fraser, 1992; Strader et al., 1994), 
indicating that this residue is of vital importance in the signal transduction 
mechanism. Moreover, mutation of Asn1·50 of the a18-adrenergic receptor to Ala 
resulted in a constitutively active receptor (Scheer et al., 1996). It will be of interest 
to investigate the effects of mutating Asn 1·50 of the GnRH receptor, on G protein 
coupling and signal transduction. 
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Support for the role of TM7 residues in the mechanism for initially maintaining the 
inactive R conformation of GPCRs, followed by their isomerization from R~R* in 
response to agonist, has come from mutagenesis studies of the highly conserved 
NP(Xh.3 Y motif, of which Asn7.49 and Tyr7.53 form a part. Both the substitution of 
. Asp318(7·49> with Asn and replacement of Tyr322(7.s3> with Ala markedly impaired the 
ability of the GnRH receptor to interact with G proteins and to couple to inositol 
phosphate production (Arora et al., 1996). Similar findings have been reported for 
the gastrin-releasing peptide (Slice et al., 1994) and AT1A (Hunyady et al., 1996; 
Laporte et al., 1996) receptors, while mutation of Asn7.49 to Ala resulted in complete 
uncoupling of the f32-adrenergic receptor (Barak et al., 1995). These results suggest 
that rather than being purely an internalization motif as reviewed in Section 1.3.3.3, 
the NP(X)2,3 Y sequence, with Asn
7
.4
9 and Ty?·53 being the functional residues that 
interact with Asn1·50, Asp2·50 and Arg3·50, may function as a critical determinant for 
stabilizing the R conformation of GPCRs and in mediating the changes in that 
conformation in response to agonist. 
The present finding that the mD138N mutant receptor, in which the negative charge 
at position 3.49 is removed, showed an increased coupling efficiency, suggests that 
protonation of this residue could be involved in GnRH receptor activation. 
Constitutive activation of the GnRH receptor was not observed when Asp 138(3.49) was 
mutated to Ala, as reported by Scheer et al. (1996) for the a 18-adrenergic receptor. 
The observation of the present study that the mD138A mutant GnRH receptor 
displayed no detectable agonist binding, antagonist binding, or IP production, most 
likely indicates gross misfolding, or failure of expression of this receptor. 
In summary, the models of Scheer et al. and Ballesteros et al. predict that 
protonation of Glu/Asp3.49 results in the release of the positively charged Arg3·50 side-
chain, possibly toward the cytosol, where it can participate in G protein activation. In 
the models of Oliveira et al. and Scheer et al., Arg3·50 is involved in a network of 
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hydrogen bonding interactions with Asn1·50, Asp2·50, Asn7.49 and Tyr7·53, while the 
model of Ballesteros et al. places Arg3·50 in an ionic interaction with Glu/Asp3.49. In all 
three models, these interactions are predicted to stabilize the receptor in the R state. 
The removal of the positive charge at position 3.50 could therefore destabilize the 
inactive conformation of the receptor and also disrupt receptor-G protein coupling. 
The model of Oliveira et al. implicates the highly conserved Leu2.46 in modulating the 
orientation of the Arg3·50 side-chain through hydrophobic interaction, while this 
function is fulfilled by the highly conserved lle3·54 in the model of Ballesteros et al. In 
both cases, it is a bulky ~-branched side-chain (Leu/lie) orientating the Arg3·50 side-
chain. The results of the present study are consistent with all three of the above 
models. Further studies are required in order to determine which model is 
more applicable to GnRH receptor activation. 
3.2.4 C~mparison of internalization of agonist- and antagonist-occupied receptors 
Before considering the relationship of internalization to receptor activation for the 
GnRH receptor, it was necessary to address the related question of whether 
agonists and antagonists differ with respect to their internalization behaviour. A 
review of the literature (see Section 1.3) indicates that the relationship between 
GPCR activation and internalization, remains unclear. Some studies have reported 
very slow or no internalization of antagonist-occupied receptors (Hoelscher et al., 
1991; Lutz et al., 1992; von Zastrow et al., 1994; Williams et al., 1998), while others 
have reported substantial antagonist-occupied receptor internalization (Roettger et 
al., 1997, Pfeiffer et al., 1998). 
A simple and widely used method for measuring GPCR internalization is the acid-
wash method, in which receptor-bound ligand is released by low pH, and this proved 
adequate for use with agonist radioligands of the GnRH receptor. However the acid-
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wash method proved unsuitable for the GnRH antagonist radioligand, presumably 
due to strong hydrophobic interactions between the antagonist peptide and the 
receptor, which are not susceptible to disruption by low pH. This behaviour is not 
unusual for GnRH receptor antagonists, as similar observations of either very slow 
dissociation or a nondissociable component of antagonist binding, have previously 
been reported (Loumaye et al., 1984; Li et al., 1994). For this reason, the DAB 
cross-linking method, which has not previously been used in the GPCR field, was 
developed for the GnRH receptor. The DAB cross-linking method overcomes the 
problem previously encountered, gave similar results to the acid-wash method for 
agonist internalization, and thus proved suitable for use with GnRH antagonist 
radioligand Antagonist 26. 
The results showed unequivocally that the GnRH antagonist-occupied receptors 
were internalized very slowly if at all, compared with agonist-occupied receptors. 
This result implies that receptor activation is a critical requirement for GnRH receptor 
internalization. However, this study should be extended to include other GnRH 
receptor antagonists, before this conclusion can be generalized. 
3.2.5 Role of Arg 139 in internalization 
The present study demonstrates a role for Arg3·50 in agonist-promoted internalization 
of the GnRH receptor. Internalization of the mR139Q GnRH receptor was decreased 
to 38-52% of wild type, measured using two independent methods. This is consistent 
with the reported effects of the R3.50G mutation in the gastrin-releasing peptide 
receptor and in the R3.50H mutation in the lutropin/choriogonadotropin receptor, 
both of which showed impaired agonist-promoted internalization (Benya et al., 1994; 
Dhanwada et al., 1996). Similar findings were reported for the mR 1390 GnRH 
receptor in the recent work of Arora et al. (1997). Interestingly, the degree of 
impairment of internalization of the mR139Q GnRH receptor was less severe than 
the effect of the mutation on coupling, which was decreased to 6% of wild type (see 
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Section 3.1.1 ), suggesting that coupling and internalization are dissociated to some 
extent. 
To investigate whether the decrease in internalization seen in the mR139Q GnRH 
receptor was due to a failure of this uncoupled r~ceptor to activate PKC, the effect of 
PKC activation by phorbol ester on agonist-promoted internalization of wild type and 
mR139Q GnRH receptors was examined. Although PMA treatment enhanced 
internalization of both wild type and mR139Q GnRH receptors, it did not restore 
internalization of the uncoupled mutant to the wild type level. These results are 
consistent with those reported for mutant gastrin-releasing peptide (Benya et al., 
1994) and thyrotropin-releasing hormone receptors (Nussenzveig et al., 1993b), and 
indicate that while PKC may play a modulatory role in agonist-promoted 
internalization, the impairment of internalization in the mR139Q mutant cannot be 
attributed solely to its inability to activate PKC. 
Evidence that coupling and internalization can be dissociated has come from studies 
of mutant receptors that were uncoupled, but were found to internalize normally 
(Cheung et al., 1990; Hausdorff et al., 1990, Campbell et al., 1991 ). This implies that 
receptor-G protein coupling is not generally necessary for agonist-promoted 
internalization of all GPCRs. Conversely, impaired internalization has been reported 
for mutant receptors that displayed functional coupling and full activation of their 
effector systems (Lameh et al., 1992; Benya et al., 1993). Taken together, these 
studies indicate that receptor-mediated activation of a cognate G protein followed by 
second messenger production, is neither sufficient nor necessary for agonist-
promoted internalization of GPCRs. The conclusion that emerges, is that agonist-
promoted internalization is mediated by interactions of the cells internalization 
'machinery' with structural motifs on the receptor which may or may not overlap with 
the motifs involved in G protein coupling. 
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Since an intact Arg-cage has been shown to be important for receptor-G protein 
coupling (Ballesteros et al., 1998), it was of interest to determine whether an intact 
Arg-cage structure is also essential for efficient internalization of the GnRH receptor. 
The finding that the hi143L mutant displayed a wild type level of internalization is 
consistent with the results of Ballesteros et al. (1998) who reported that this mutant 
behaved essentially as the wild type receptor for both ligand binding and signal 
transduction efficiency. The branched bulky side-chain of the Leu residue is similar 
to that of lie, and is evidently able to substitute for it in facilitating a favourable 
conformation of Arg 139 according to the model. In contrast, when an Ala residue is 
placed at this position, the lack of a branched bulky side-chain would result in an 
incorrectly oriented Arg side-chain, based on the predictions of the Arg-cage model 
(Ballesteros et al., 1998), hence the inefficiency in mediating signal transduction. 
The present finding, that the hi143A mutant was poorly internalized, suggests that 
an intact Arg-cage is also essential for agonist-promoted internalization of GnRH 
receptor. 
In summary, the findings of the present study demonstrate a critical role for Arg3·50 in 
coupling of the GnRH receptor, but not in temperature modulation of agonist binding. 
The mR139Q GnRH receptor also showed impaired agonist-promoted 
internalization, which was not due to a failure to activate PKC as a result of its 
uncoupling. The mR139Q receptor was expressed in markedly increased numbers 
on the cell surface. The reasons for this are not clear, but the impaired 
internalization may be a contributing factor. Though highly conserved in GPCRs, the 
negative charge of Asp3·49 was found to be unnecessary for coupling or 
internalization of the GnRH receptor. Interestingly, the mD138N mutant showed 
increased coupling efficiency and internalization, suggesting that the removal of the 
negative charge on Asp138<3.49) perturbs the receptor conformation equilibrium 
(R~R*) towards the. activated state. In addition, the DAB cross-linking method was 
used for the first time for measuring the internalization of agonist- and antagonist-
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occupied GPCRs. Using this method, antagonist-occupied GnRH receptors were 
shown not to undergo internalization, suggesting that receptor activation is a critical 
determinant for GnRH receptor internalization. 
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4 STRUCTURE-FUNCTION MAPPING OF THE CYTOPLASMIC TAIL OF THE 
CHICKEN GnRH RECEPTOR. IN MEDIATING AGONIST-PROMOTED 
INTERNALIZATION 
4.1 . RESULTS 
As described in Section 1.4.1, the non-mammalian GnRH receptors possess 
cytoplamsic C-terminal tails, unlike their mammalian counterparts. In order to test the 
role of the cytoplasmic C-terminal tail in agonist-promoted internalization of the 
chicken GnRH receptor (Figure 6), and to map the regions required for the 
internalization process, several mutant chicken GnRH receptors were constructed in 
which either progressively larger portions of the cytoplasmic tail were deleted, or Ser 
and Thr residues were substituted with Ala. These receptor mutants are shown 
schematically in Figure 30. 
4.1.1 Optimization of the acid-wash method of measuring agonist-promoted 
internalization of chicken GnRH receptors 
The agonist ligand [His5 , D-Tyr6]GnRH was found to give the best binding to the 
chicken GnRH receptor, and was used for internalization studies. In the experimental 
protocol used here, 1251-[His5, D-Tyr6]GnRH binding to intact cells was allowed to 
reach equilibrium at 0°C, under which conditions receptor internalization does not 
occur. The time-course of binding of 1251-[His5, D-Tyr6]GnRH to wild type human and 
chicken GnRH receptors (Figure 31) shows that binding equilibrium is approached 
after 5 hrs at 0°C, when 1 05 cpm 1251-[His5, D-Tyr6]GnRH is added per well. A 5 hr 
pre-incubation at ooc was therefore used for further internalization studies. 
Following warming of cells to 37°C, 1251-[His5, D-Tyr6]GnRH internalization was 
measured as a function of time. 
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4.1.2 Comparison of internalization of human and chicken GnRH receptors 
Radioligand receptor-mediated internalization, expressed as either % of total cell-
associated ligand (Figure 32a) or absolute amount of internalized ligand (Figure 
32b), showed markedly different kinetics for the wild type human and chicken 
receptors. The wild type chicken GnRH receptor showed rapid internalization (75% 
in 15 min), compared with much slower internalization by the wild type human 
receptor (7% in 15 min) (Figure 32a). The rapid internalization of the wild type 
chicken GnRH receptor was accompanied by a decrease in cell surface radioligand 
(80% in 90 min) (Figure 32c). In contrast, cell surface binding of the wild type human 
GnRH receptor increased slowly with time (2-fold over 90 min) (Figure 32c). 
The % internalization data were fitted to equation 4 (Section 2.9.1) by non-linear 
regression, which yielded values for Fmax and A.. The internalization rate constants 
(k2) and the recycling rate constants (1<:3) were derived using equations 9 and 1 0 
(Section 2.9.1 ). 
The rate constants for wild type chicken and human receptor internalization were 
1 0.2%.minc1 and 0.71 %.min-1 respectively, while the rate constants for recycling for 
the two receptors were similar at 2.37%.min-1 and 1.64%.min-1. Thus the chicken 
receptor internalized 15-fold faster than the human receptor. 
TABLE 9 AGONIST-PROMOTED INTERNALIZATION PARAMETERS FOR CHICKEN WILD TYPE 
AND TRUNCATED GnRH RECEPTORS 
cWT cS366stop cD356stop cT351stop cS346stop cS337stop hWT 
-----------------------------------------------------------------------------------------
X a 10 20 25 30 39 
b 
FMAX 81.1±0.8 72.9±1.0 58.0±2.8 51.7±3.1 57.9±3.6 21.5±2.6 30.2±3.9 
')..c 0.126±0.008 0.057±0.003 0.035±0.004 0.031±0.005 0.023±0.003 0.023±0.006 0.024±0.006 
k2d 10.2 4.14 2.00 1.60 1.35 0.50 0.71 
kae 2.37 1.54 1.45 1.50 0.98 1.84 1.64 
a The number of residues removed in each truncation mutant. 
b FMAX , the extrapolated maximal% internalization at equilibrium, was determined by curve fitting of mean data from three 
independent experiments 
c A., the time constant in min -1, determined by curve fitting. 
d k2, the internalization rate constant in %.min -\was calculated from equation 9, Section 2.9.1. 
e k3, the recycling rate constant in %.min -
1
, was calculated from equation 10, Section 2.9.1. 
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4.1.3 Truncation mutations of the cytoplasmic tail of the chicken GnRH 
receptor 
To determine whether the cytoplasmic C-terminal tail was responsible for the rapid 
agonist-promoted internalization of the chicken GnRH receptor compared with its 
human counterpart, the tail was truncated after lle336. Maximal internalization (Fmax) 
of the cS337stop mutant was decreased to 21.5±2.6% compared with 81.1±0.8% for 
the wild type chicken receptor (Figure 32a, Figure 33, Table 9), and was similar to 
that of the wild type human receptor (30.2±3.9%) (Figure 31a, Table 9). Cell surface 
binding of the cS337stop mutant receptor was similar to the wild type human 
receptor, increasing slowly with time (Figure 32c). A more truncated receptor 
(cR330stop) showed no detectable agonist binding and IP production (unpublished 
work, A Katz and J. Lopes in our laboratory). 
In order to more precisely localize the tail elements critical for the internalization 
process, four additional truncations were constructed and tested (Figure 33, Table 
9). Maximal internalization (Fmax) for the cS366stop, c0356stop, cT351 stop, and 
cS346stop mutants decreased progressively with the removal of increasing numbers 
of tail residues (Table 9). 
The parameter most dramatically affected by truncations of the tail was the 
internalization rate constant (k2), which decreased by 20-fold, from 10.2 %.min·1 in 
the wild type chicken receptor, to 0.50 %.min·1 in the cS337stop truncation mutant 
(Table 9, Figure 34). In contrast, the recycling rate constant ~varied by a maximum 
of 2.4-fold over the series of truncation mutants (Table 9, Figure 34). 
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4.1.4 Point-mutations of Ser and Thr residues in the cytoplasmic tail of the 
chicken GnRH receptor 
To identify which residues of the cytoplasmic C-terminal tail are required for agonist-
promoted internalization of the chicken GnRH receptor, Ser/Thr residues were 
substituted with Ala. Serine and threonine residues were chosen for mutation since 
these amino acids have been shown previously to be sites for receptor 
phosphorylation, and to modulate the internalization of other of GPCRs (Section 
1.3.2.2). 
TABLE 10 AGONIST-PROMOTED INTERNALIZATION PARAMETERS FOR 


























a FMAX , the extrapolated maximal % internalization at equilibrium, was determined by curve fitting of mean data 
from three independent experiments 
b A., the time constant in min'1, determined by curve fitting. 
c k2, the internalization rate constant in %.min'1, was calculated from equation 9, Section 2.9.1 
d ks. the recycling rate constant in %.min·1, was calculated from equation 10, Section 2.9.1 
Since the truncation analysis had indicated that the largest effects on internalization 
were seen with the removal of the regions Ser337-Ser346 and Asp356-C-terminus (Table 
9), the Ser and Thr residues in these segments were chosen for point-mutation to 
Ala. As shown in Figure 35 and Table 10, each of these point-mutations caused 
decreased internalization compared with the wild type chicken receptor, although the 
decreases were less marked than seen with the truncation mutants. The parameter 
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most affected by the SerfThr point-mutations was the internalization rate constant k2. 
The greatest decrease in k2 (5-fold) was seen in the Thr36srhr370 double mutant 
(Table 1 0). The recycling rate constant ~ was much less affected by the point-
mutations, showing a maximum 1.5-fold change from the wild type chicken receptor, 
which is probably witt'J experimental error (Table 1 0). 
4.1.5 The role of dynamin in chicken GnRH receptor agonist-promoted 
internalization 
TABLE 11 AGONIST-PROMOTED INTERNALIZATION PARAMETERS FOR WT 
CHICKEN GnRHR IN THE PRESENCE OF CO-EXPRESSED WT DYNAMIN I AND 
















a FMAX , the extrapolated maximal % internalization at equilibrium, was determined by curve fitting of mean data 
from three independent experiments 
b A., the time constant in min"\ determined by curve fitting. 
c k2, the internalization rate constant in %.min"1, was calculated from equation 9, Section 2.9.1 
d ka, the recycling rate constant in %.min"\ was calculated from equation 10, Section 2.9.1 
To investigate the role of dynamin in chicken GnRH receptor internalization, the 
ability of wild type rat dynamin I and dominant-negative mutant dynamin I-K44A 
constructs to influence the internalization of co-transfected chicken GnRH receptors 
in COS-1 cells was tested. Agonist-promoted internalization of the wild type chicken 
GnRH receptor was unaffected by the presence of co-transfected dynamin I (Figure 
36), whereas co-transfection of dynamin I-K44A inhibited internalization, as reflected 
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by the 48% decrease in the internalization rate constant k2 (Figure 36, Table 11 ). 
The recycling rate constant ~was little affected by the co-expression of dynamin I-
K44A, showing only a 1.5-fold change from the wild type chicken receptor in the 
absence of mutant dynamin I-K44A. When the amount of dominant-negative 
dynamin I-K44A eDNA co-transfected was increased,. the level of internalization of 
wild type chicken GnRH receptor decreased in a dose-related manner (Figure 37). In 
contrast, co-transfected dynamin I-K44A had no effect on internalization of wild type 
human and cS337stop GnRH receptors, which lack C-terminal tails (Figure 36). 
4.2 DISCUSSION 
Mammalian GnRH receptors show structural features which are unique in the GPCR 
family, the most striking of which is the absence of a C-terminal tail (Tsutsumi et al., 
1992). The recent cloning of the catfish (Tensen et al., 1997), chicken, goldfish and 
frog (Troskie et al., 1997) GnRH receptors has revealed that these non-mammalian 
receptors all possess cytoplasmic C-terminal tails. This presented the opportunity to 
investigate the role of the tail on GnRH receptor function. Since the C-terminal tail 
has been shown to be involved in internalization for a number of GPCRs (see 
Section 1.3.3.4), the effect of this structural difference on the agonist-promoted 
internalization of the human and chicken GnRH receptors was investigated. 
For the analysis of receptor internalization data, a simple mathematical model was 
derived from first principles as described in Section 2.9.1. This model describes 
receptor trafficking in terms of four fluxes (r1, r2, r3, r4), and it was assumed that the 
rates of new receptor synthesis (r1) and receptor degradation (r4) were small 
compared to the rates of internalization (r2) and recycling (r3). The assumption that 
· r4 could be neglected is reasonable on the basis of the degradation rate 
experimentally observed using photoaffinity-labeled GnRH receptors (Section 
5.2.2). Furthermore, under steady-state conditions, the total number of receptors is 
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constant, and therefore r1 = r4 under these conditions. It is therefore not 
unreasonable to assume that r1 is also small compared with r2 and r3, and can be 
neglected in the analysis. 
The experimental internalization data were fitted to the equation derived from the 
above model, yielding the fitted parameters Fmax and A.. The internalization rate 
constant (k2) and the recycling rate constant (~)were calculated from Fmax and A.. It 
is important to note that decreased 'internalization' manifested by a decreased Fmax 
could result either from a decrease in k2 (internalization rate constant) or from an 
increase in ~ (recycling rate constant). These two possibilities are depicted 
graphically in Figure 38. It is evident that the determination of experimental data at 
early time-points is required to distinguish between them. 
The finding that the wild type chicken GnRH receptor displayed a markedly higher 
internalization rate than the wild type human receptor, suggested that the presence 
of the cytoplasmic tail mediated rapid chicken GnRH receptor internalization. This 
was confirmed by truncation of the C-terminal tail of the chicken GnRH receptor at 
position 337, which resulted in a receptor that behaved similarly to the wild type 
human receptor. Interestingly, despite their widely differing internalization rates, the 
chicken and human receptors displayed similar recycling rate constants. 
Truncation of the cytoplasmic tail of the chicken GnRH receptor resulted in dramatic 
decreases in the internalization rate constant k2 (up to 20-fold), while the recycling 
rate constant ~was little affected (less than 2.4-fold change). These data indicate 
that internalization specifically requires structural determinants located in the 
cytoplasmic tail, while recycling is relatively independent of these structural motifs. 
There was a progressive decrease in k2 as more tail residues were removed, 
indicating that the structural determinants for internalization are located in all regions 
of the tail (distal to lle336). However, the relative magnitudes of the changes in the 
truncation mutants indicated that the major determinants of internalization lie in two 
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regions (a) between Asp356 and the C-terminus and (b) between Ser337 and lle345• 
These two regions were therefore targeted for point-mutation of Ser and Thr 
residues to Ala. 
Ea~ of the Serffhr point-mutations caused an impairment of internalization as 
reflected in a decreased k2• The greatest decrease was seen in the double mutant 
where the doublet of Thr369 and Thr370 was mutated. In this mutant, the impairment of 
internalization (5-fold decrease in k;) was equivalent to that seen in the cD356stop 
truncation, indicating that these residues are critical for the function of this segment, 
and suggesting that they may be critica'l sites of phosphorylation for modulation of ~­
arrestin binding. 
Mutation of other Serrfhr residues caused smaller decreases in k2, suggesting that 
their phosphorylation may also contribute to internalization but is quantitatively less 
important. The recycling rate constant ~was affected little by any of the Serffhr 
point-mutations, including the Thr~hr370 doublet. This confirms the conclusion from 
the truncation mutants, that receptor recycling is independent of structural 
determinants in the cytoplasmic C-terminal tail. 
A shortcoming in using truncated receptors to identify signals for internalization, is 
that it is not possible to determine whether internalization is being regulated by 
specific amino acid residues or whether internalization is a/so modulated by the 
length of the receptor's tail. A critical length of the cytoplasmic tail, perhaps 
combined with a specific internalization signal, could be required to allow interaction 
with the internalization 'machinery' of the cell. Findings with several GPCRs, 
including the gastrin-releasing peptide (Benya et al., 1993), Thyrotropin-releasing 
hormone (Nussenzveig et aL, 1993a), AT1A (Hunyady et al., 1994b), Neurotensin 
(Chalbry et al., 1995), and 8 Opioid (Trapaidze et al., 1996) receptors (Section 
1.3.3.4), have shown that the length of the cytoplasmic tail is important, insofar as its 
truncation atte6uated internalization rates. In contrast, truncation of the 
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lutropin/choriogonadotropin receptor to residue 631, which is ten amino acids distal 
to the conserved palmitoylation site Cys residues, caused that mutant receptor to 
internalize to an higher level (Fmax) than wild type (Rodriguez et al., 1992). 
Interestingly, the increased internalization rate constant (k2) observed for the 
631 stop truncated lutropin/choriogonadotropin receptor was coupled to an increased 
rate of degradation of internalized hCG hormone, presumably due to an increase in 
the rate at which hormone is delivered to the lysosomes. The effects of truncations 
of the cytoplasmic tail of P2-adrenergic receptors are complex. Truncation of the 
human J32-adrenergic receptor at position 365, which is twenty-three amino acids 
distal to the conserved palmitoylation site Cys residue (Cys34\ caused the mutant to 
be _internalized to a higher Fmax than wild type (Bouvier et al., 1988). Truncation of 
the hamster J32-adrenergic receptor at position 354, twelve amino acids distal to the 
conserved palmitoylation site Cys residue (Cys341 ), did not effect internalization 
(Strader et al., 1987; Cheung et aL, 1989), whereas truncation at residue 345 
decreased the Fmax of internalization, the result of a decrease in the internalization 
rate constant (k2) (Cheung et al., 1989). 
For non-GPCRs, such as the low density lipoprotein, transferrin, human 
asialoglycoprotein and bovine cation-independent mannose-6-phosphate receptors, 
distinct small peptide sequences in the cytoplasmic tails (Asn-Pro-Vai-Tyr, Tyr-Thr-
Arg-Phe, Tyr-Gin-Asp-Leu, and Tyr-Lys-Tyr-Ser-Lys-Val respectively) all containing 
a tyrosine residue, have been identified as receptor internalization signals. These 
Tyr containing peptide sequences have been shown to occur predominantly in J3-
turns (Trowbridge, 1991 ), suggesting that a Tyr residue in the context of a J3-turn is a 
characteristic feature of internalization signals, at least for constitutively recycling 
receptors. Whether or not such a motif could play a similar role in GPCRs, is 
unclear. However, for at least two GPCRs, the parathyroid hormone (Huang et al., 
1995) and neurotensin (Chalbry et al., 1995) receptors, tyrosine has been suggested 
or identified to be important for internalization. Furthermore, it has also been shown 
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that the medium chains (~1 and ~2) of clathrin-associated protein complexes AP-1 
and AP-2 respectively (Section 1.3.2.1 ), can specifically interact with a Tyr-based 
signal YXX<P (where X is any amino acid, and <P an amino acid with a bulky 
hydrophobic side-chain) motif (Ohno et al., 1995). The Tyr-Thr-Arg-Phe 
internalization signal of the transferrin receptor bears a strong resemblance to the 
aforementioned Tyr-based signal. 
The present results may be of value in identifying an internalization motif in GPCRs. 
Tyrosine residues obviously do not play a critical role in GnRH receptor 
internalization, since the cytoplasmic tail of the chicken GnRH receptor internalizes 
very rapidly, yet contains no Tyr residues. The sequence Ser-Thr-Leu in the AT1A 
receptor was determined to play an essential role in its internalization (Hunyady et 
al., 1994b). In addition, it was suggested that the cytoplasmic tail sequence Thr-Ser-
lle-Ser of the human 81 kinin receptor may be involved in its internalization 
(Faussner et al., 1998). The present results show that the Thr369-Thr370-Val371 
sequence of the chicken GnRH receptor cytoplasmic tail is critical for internalization. 
Thus, it appears that Thr/Ser-Thr/Ser-lle/LeuNal may constitute a motif for 
internalization of some GPCRs. Interestingly, this motif is also present in the tails of 
several GPCRs including the ~2-adrenergic, D1-dopamine, glucagon-like peptide-1, 
human interleukin-8, lutropin/choriogonadotropin, human neurokinin A, rat 
neurotensin, and rat substance P receptors. Its role in mediating internalization in 
these receptors has not been investigated and will be of interest. 
Studies of GnRH receptor desensitization from this laboratory reported that the 
absence of a tail in mammalian GnRH receptors is correlated with an absence of 
rapid homologous desensitization of phospholipase C activation by these receptors 
(see Section 1.4.3). It remains to be determined whether the wild type chicken 
GnRH receptor undergoes rapid desensitization of its signaling function and whether 
or not the cytoplasmic tail plays a role in this event. The absence of the cytoplasmic 
104 
C-terminal tail in mammalian GnRH receptors and its presence in non-mammalian 
vertebrate GnRH receptors suggests this may have physiological correlates in 
mammals and non-mammals. The absence of the cytoplasmic tail may have been 
selected to prevent rapid desensitization and internalization of mammalian GnRH 
receptors, in order to keep a large number of active ~eceptors on the cell surface to 
allow a protracted LH surge over several hours which is required for ovulation in 
mammals. In contrast the chicken has a one day cycle, which includes a 
substantially shorter LH surge of no more than 2 hrs (Furr et al., 1973). 
Since Dynamin (Section 1.3.2.3) has been shown to modulate the internalization of 
GPCRs, it was of interest to investigate its effect on chicken GnRH receptor 
internalization. Dynamin colocalizes with clathrin (has been demonstrated to bind to 
a component of AP-2, Section 1.3.2.3) and contributes to the early stages of 
internalization by catalyzing the GTP-dependent disconnection of CCVs from the 
plasma membrane. The finding that overexpression of dominant-negative dynamin I-
K44A mutant led to a decrease in wild type chicken GnRH receptor internalization 
implies that internalization proceeds via a dynamin-dependent pathway, and thus 
could internalize via clathrin-coated vesicles. That overexpression of wild type 
dynamin I did not significantly increase chicken GnRH receptor internalization could 
be explained by the possibility that COS-1 cells (used here) have an endogenous 
over-abundance of dynamin, and that only overexpression of a dominant-negative 
mutant dynamin that competes with wild type dynamin, will show any effect. 
In conclusion, the findings of the present study show that the cytoplasmic C-terminal 
tail of the chicken GnRH receptor is essential for agonist-promoted internalization. 
The internalization rate of the wild type chicken GnRH receptor internalization was 
15-fold more rapid than its human counterpart, and truncation of the cytoplasmic tail 
resulted in a decrease in internalization rate to a level equivalent to the wild type 
human receptor. These results suggest that the loss of the tail during evolution of the 
mammalian GnRH receptor may be related to its effects on internalization. In 
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contrast, the recycling rates of human, chicken, and truncated chicken receptors 
were found to be similar. The results show that a Thr-Thr doublet located near the C-
terminal end are the most important residues. Comparison of the present data with 
those obtained for other GPCRs shows that the motif Thr/Ser-Thr/Ser-lle/LeuNal 
may be an internalization sequence._ The present results also provide evidence that 
internalization of the chicken GnRH receptor is dependent on the GTPase dynamin, 
thus providing evidence that this process proceeds via clathrin-coated vesicles. 




A quantitative description of receptor trafficking requires that an estimate of receptor 
degradation rate be determined. Photoaffinity labeled receptors can be visualized on 
SDS-PAGE gels using autoradiography, allowing receptor degradation to be 
visualized by a decrease in molecular weight and/or a decrease in labeling intensity. 
A prerequisite for such studies is that the photoaffinity ligand should cross-link to the 
receptor in a relatively stable manner (i.e. the rate of decay of the cross-link should 
be slow compared with the receptor degradation rate). 
5.1.1 Determination of the in vitro stability of the 1251-[N-azidobenzoyi-D-
LysiGnRH cross-link to the GnRH receptor 
UV-induced cross-linking of 1251-[N-azidobenzoyi-D-Lys6]GnRH to mouse GnRH 
receptors endogenously expressed in the mouse pituitary gonadotrope aT3~1 cell-
line, followed by SDS-PAGE and autoradiography revealed specific labeling of broad 
bands with apparent molecular weights of ±45 kDa (Figure 39, lanes 1 and 2). The 
broadness of the band was due to heterogeneity of receptor glycosylation, as 
deglycosylation of the labeled membranes with peptide N-glycosidase F (PN-gase F) 
resulted in visualization of a sharp band of 32 kDa (Figure 39, lanes 3 and 4). The 
sharp bands appearing at ±27kDa (Figure 39, lanes 1 and 2) are probably non-
specifically labeled membrane components, or they may represent degraded GnRH 
receptor fragments. The absence of bands of lower molecular weight than the 
deglycosylated receptor (Figure 39, lanes 3 and 4) suggests the absence of receptor 
degradation during the 18 hr deglycosylation step. 
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To assess the in vitro stability of the covalent cross-link of 1251-[N-azidobenzoyi-D-
Lys6]GnRH to the GnRH receptor, photoaffinity labeled membranes were incubated 
at 37°C for various time-points up to 24 hrs. To prevent proteolytic degradation of 
the ligand-receptor complex, various protease inhibitors were included during the 
inc!Jbation period. In Figure 40, receptor degradation (i.e. the appearance of lower 
molecular weight fragments) is already evident at 0 hrs incubation in the absence of 
protease inhibitors (leupeptin and PMSF), while inclusion of the inhibitors prevented 
GnRH receptor degradation up to approximately 6 hrs, after which degradation was 
clearly visible (Figure 40, lanes 9-12). In the experiment shown in Figure 42, EDTA 
was also included as a protease inhibitor, in addition to leupeptin and PMSF. Once 
again, the protease inhibitors were effective at preventing receptor degradation up to 
approximately 6 hrs. Since there was no degradation seen in Figure 39, this would 
indicate that there was variability of degradation in the different receptor 
preparations. 
Pre-incubation of labeled membranes for 1 0 min at 60°C was performed to heat 
inactivate proteases (Figure 43), demonstrating a slow decrease in labeling over 24 
hours. Receptor degradation (i.e. the appearance of lower molecular weight 
fragments) was evident in lanes 7 and 8 (Figure 43) in which no 60°C inactivation 
step was included. 
The data of Figure 40 were quantitated and fitted to the exponential decay equation, 
as shown in Figure 41. This yielded a value of 0.05%.min-1 for the in vitro decay rate 
constant, corresponding to a half-life of 23.2 hrs. 
108 
5.1.2 Intracellular degradation of 1251-[N-azidobenzoyi-D-Lys1GnRH cross-
linked GnRH receptor 
Intact cells were photoaffinity labeled with 1251-[N-azidobenzoyi-D-Lys6]GnRH to 
determine the rate of degradation of the ligand-receptor complex in vivo. Intact a.T3-1 
cells, covalently labeled with 1251-[N-azidobenzoyi-D-Lys6]GnRH were returned to cell 
culture and incubated at 37°C for various time-points up to 24 hrs. The cells were 
then harvested and processed for SDS-PAGE and autoradiography as described in 
- Section 2.8.3. The radioactivity in the GnRH receptor bands (Figure 44) were 
quantitated and the data fitted by non-linear regression to a single component 
exponential equation (Figure 45), yielding a half-life of degradation of 4.8 hrs, which 
corresponds to a degradation rate constant~= 0.24%.min·1. Radioactivity released 
into the medium at each time-point, mirrored the degradation of labeled GnRH 
receptors (Figure 45), while the total radioactivity at each time-point remained 
constant. 
5.2 DISCUSSION 
The results of the present study demonstrate that the cross-link between the mouse 
GnRH receptor and the photoreactive GnRH analog, 1251-[N-azidobenzoyi-D-
Lys6]GnRH is stable enough to allow an estimate of the rate of intracellular 
degradation of the mouse GnRH receptor, which was shown to have a half-life of 4.8 
hrs. 
The importance of determining the stability of the cross-link is clear. Should the 
photoreactive agonist begin to dissociate from its binding pocket on the receptor as 
a result of an unstable cross-link, the decreasing intensity of the bands in Figure 44 
would be due to a combination of both degradation and photoreactive agonist 
dissociation. It was necessary to include protease inhibitors during the incubation 
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steps, since rapid receptor degradation was observed in some experiments (Figures 
40 and 42). The choice of inhibitors, leupeptin, PMSF, and EDTA, was made to 
cover as broad a spectrum of proteases as possible. Nevertheless, these protease 
inhibitors were ineffective after approximately 6 hrs (Figures 40 and 42). An 
alternative means qf inactivating proteases is a high temperature pre-_incubation step 
(60°C for 10 min). However, this procedure had the undesirable effect of causing 
aggregation of photoaffinity-labeled GnRH receptors, rendering their quantitation in 
gels unreliable. 
The slow decrease in labeling intensity with incubation in vitro could be due to (a) 
chemical instability of the cross-link, or (b) proteolytic degradation by proteases 
resistant to the inhibitors used. The latter interpretation is the most likely, as residual 
proteolytic degradation in the presence of inhibitors was revealed by a decrease in 
molecular size of the labeled bands at late time points. However, a combination of 
proteolytic degradation plus cross-link instability cannot be ruled out by the present 
data. To estimate the true in vivo degradation rate, the decrease in receptor labeling 
observed in vivo over time should be corrected for the contribution due to chemical 
decay of the cross-link. In quantitative terms, the intensity l(t) of the labeled band 
would decrease with time, t, according to the equation 
l(t) = Ia . e-kS.t 
or, l(t) = Ia . e-(k4 + kS)t 
where ~ is the receptor degradation rate constant (see Section 2.9.1) and ks is the 
cross-link decay rate constant. Thus to correct for cross-link decay, the estimated 
value for ks should be subtracted from the observed in vivo decay rate constant. 
As the contribution of decay due to protease activity could not be accurately 
quantitated, the present data show only that the cross-link used in these experiments 
is either stable or decays slowly, with a maximum estimate of ks = 0.05%.min-1. 
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If the cross-link is assumed to be stable, the in vivo degradation rate constant ~ is 
estimated to be 0.24%.min·1. However, if this assumption were incorrect, and the 
correction for cross-link decay is applied, a value of~= 0.19%.min·1 is obtained. In 
any event, the cross-link is sufficiently stable not to influence the overall 
interpretation of the· results. 
The methodology of the protocols presented in this chapter were initially designed in 
order to monitor the intracellular trafficking of the photoaffinity-labeled GnRH 
receptor on 50S-polyacrylamide gels. The advantage of using a photoaffinity-
labeled receptor, is that the progress of the receptor can be followed. The widely 
used acid-wash method for measuring internalization, in reality measures ligand 
rather than receptor internalization. Thus, once the ligand had dissociated from the 
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receptor, assuming it does, the pathway that the receptor follows cannot be further 
characterized. Utilizing a photoaffinity ligand, which is covalently attached to the 
receptor, an entire 'round-trip' of endocytosis including, internalization, recycling, 
and degradation could, in theory, be characterized. 
In order to monitor the intracellular pathway of a photoaffinity-labeled receptor, those 
receptors on the cell surface must be distinguished from intracellular receptors. 
Since the covalently attached photoaffinity ligand cannot be removed by a low pH 
acid-wash, an alternative means would be to modify cell surface receptors. Protease 
digestion of cell surface receptors in intact cells was tested. Those receptors on the 
cell surface at the time of protease treatment would be digested, and would run at a 
lower molecular weight on the 50S-polyacrylamide gel. The intracellular receptors 
would be protected from protease digestion and would run at the normal expected 
molecular weight. By quantitating the radioactivity in the two species of bands in 
each lane, the relative fractions of internal and cell surface receptors could then be 
determined. 
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The presence of two sites for trypsin cleavage (Lys residues) in the extracellular N-
terminal domain of the GnRH receptor suggested that trypsin could be utilized. 
Trypsin digestion of cell surface-labeled GnRH receptors was tested under varying 
conditions, but failed to produce digested cell surface receptors (data not shown). 
This could have been due to the inability of the enzyme to access the cleavage site . 
due to the lysine residue being either too close or embedded in, the plasma 
membrane. 
The simple mathematical model derived in Section 2.9.1, and used for the analysis 
of receptor internalization data, describes receptor trafficking in terms of four fluxes 
(r1, r2, r3, r4). One of the assumptions made in this derivation was that receptor 
degradation (r4) was small compared to rates of internalization (r2) and recycling 
(r3). The observed in vivo half-life of degradation of the mouse GnRH receptor was 
4.8 hrs corresponding to a rate constant (kt) of 0.24%.min-1. As discussed above, 
this is a maximum estimate, and kt could be lower if corrected for cross-link decay. 
Since the rate constant for degradation (kt) is an order of magnitude smaller than the 
recycling rate constant (~), it is justifiable to omit kt from the model. 
The results show that an internalized GnRH receptor has a much higher probability 
of being recycled than degraded. In most experiments in this thesis, agonist-
promoted internalization of the GnRH receptor was measured over a period of only 
90 min, during which time receptor degradation would be of the order of 20% and will 
therefore not significantly affect interpretation of the results. Furthermore, if the loss 
of covalent cross-link between ligand and receptor is taken into account, then the 
rate of degradation of GnRH receptors would in fact be even slower than that 
observed in Figure 44. It is evident from these results that GnRH receptors 
covalently labeled with tethered GnRH agonist must, on average, undergo several 
rounds of internalization and recycling, before being degraded, in the course of an 
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Figure 1. Possible heterologous desensitization pathways for GPCRs 
Schematic representation of possible GPCR heterologous desensitization pathways. 
PLC, phospholipase C; DAG, diacylglycerol; PKA, protein kinase A; PKC, protein 
kinase C; CaM-dep kinase, Ca2•-calmodulin-dependent kinase; cAMP, cyclic 
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Figure 2. Possible relationships between agonist-promoted internalization 
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Figure 3. The clathrin triskelion and clathrin coat 
Schematic drawing showing (a) the modular structure of the triskelion, and (b) the 
clathrin coat in relation to the budding vesicle. 
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Figure 4. Regulation of GPCR responsiveness 
Schematic representation of GPCR desensitization, agonist-promoted 
internalization, and resensitization following agonist activation. E, effector enzyme; 
a, ~. andy, subunits of heterotrimeric G protein;*· agonist; GRK, G protein-coupled 
receptor kinase; J3arr, J3-arrestin; P, phospha~e; +, dynamin; - - -, clathrin coat. See 




Figure 5. Amino acid sequence of the mouse GnRH receptor 
The residues mutated or investigated in this thesis are shown as filled circles. Other 
numbered residues are discussed in the text. Branched lines represent carbohydrate 
moieties, and short solid lines represent disulphide bridges. 
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Figure 6. Amino acid sequence of the chicken GnRH receptor 
The residues mutated in this thesis are shown as filled circles. The short solid line 
represents a disulphide bridge. Truncations of the cytoplasmic tail are indicated by 
short lines. 
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Figure 7. Iodination and HPLC purification of [0-AiaiGnRH 
Iodination was performed as described in Section 2.5. The iodination shown is 
typical of three iodinations. The first peak represents free 1251 followed by the peptide 
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Figure 8. Iodination and HPLC purification of Antagonist 26 
Iodination was performed as described in Section 2.5. The iodination shown is 
typical of four iodinations. The first peak represents free 1251 followed by the peptide 












Figure 9. Iodination and HPLC purification of [His5,D-Tyr1GnRH 
Iodination was performed as described in Section 2.5. The iodination shown is 
typical of four iodinations. The first peak represents free 1251 followed by the peptide 
C251-[His5, D-Tyr6]GnRH) peak at fraction 31 (*). The identity of the material eluting in 











Figure 10. GnRH agonist binding displaced by GnRH (heterologous 
displacement) in WT, D138N and R139Q mouse GnRHRs 
Displacement curves of the binding of 1251-[D-Aia6]GnRH (agonist) in the presence of 
increasing concentrations of unlabeled mGnRH to COS-1 cells expressing mWT ( ), 
m0138N (0), and. mR139Q (A) GnRHRs. Bo refers to radioligand bound in the 
absence of competing unlabeled ligand. Non-specific binding (NSB) determined in 
the presence of 1 00 nM unlabeled Antagonist 26 has been subtracted from the data. 
The experiment shown is representative of three independent experiments 
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Figure 11. GnRH agonist binding displaced by GnRH agonist (homologous 
displacement) in WT, D138N, and R139Q mouse GnRHRs 
Displacement curves of the binding of 1251-[D-Aia6]GnRH (agonist) in the presence of 
increasing concentrations of unlabeled [D-Aia6]GnRH to COS-1 cells expressing 
mWT (•), m0138N (0), and mR139Q (A) GnRHRs. So refers to radioligand bound in 
the absence of competing unlabeled ligand. Non-specific binding determined in 
parallel using untransfected COS-1 cells has been subtracted at each dilution. The 








-11 -10 -9 -8 -7 -6 
[D-Aia6 GnRH], Log M 
153 
Figure 12. GnRH antagonist binding displaced by antagonist (homologous 
displacement) in WT, 0138N, and R139Q mouse GnRHRs 
Displacement curves of the binding of 1251-Antagonist 26 in the presence of 
increasing concentrations of unlabeled Antagonist 26 to COS-1 cells expressing 
mWT (•). mD138N (0), and mR139Q (A) GnRHRs. Bo refers to radioligand bound in. 
the absence of competing unlabeled ligand. Non-specific binding determined in 
parallel using untransfected COS-1 cells has been subtracted at each dilution. The 
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Figure 13. Agonist-stimulated inositol phosphate production mediated by 
WT, D138N, and R139Q mouse GnRHRs 
The curves show total 3H-IP production in the presence of Lt in response to 
stimulation with GnRH for 1 hour at 37°C in COS-1 cells pre-labeled with (3H]-myo-
inositol and expressing mWT (•), mD138N (0), and mR139Q (A} GnRHRs. The 
experiment shown is representative of three independent experiments performed in 
duplicate. 
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Figure 14. GnRH agonist binding by WT, D138A. R139K, and R139H mouse 
GnRHRs 
The binding of 1251-[D-Aia6]GnRH (agonist) to COS-1 cells expressing mWT, 
mD138A, mR139K, and mR139H GnRHRs. 80 refers to radioligand bound in the 
absence of competing unlabeled ligand. Non-specific binding (NSB) determined in 
the presence of 1 00 nM unlabeled Antagonist 26. The experiment shown is 









Figure 15. GnRH antagonist binding by WT, D138A, R139K, and R139H 
mouse GnRHRs 
The binding of 1251-Antagonist 26 to COS-1 cells expressing mWT, mD138A, 
mR139K, and mR139H GnRHRs. Bo refers to radioligand bound in the absence of 
competing unlabeled ligand. Non-specific binding (NSB) determined in the presence. 
of 100 nM unlabeled Antagonist 26. Data points represent the mean ± S.E.M. of two 










Figure 16. Agonist-stimulated inositol phosphate production mediated by 
WT, D138A, R139K, and R139Q mouse GnRHRs 
Total 3H-IP production in the presence of Li+ in response to stimulation with GnRH 
for 1 hour in COS-1 cells pre-labeled with [3H]-myo-inositol and expressing mWT, 
mD138A, mR139K, and mR139H GnRHRs. The experiment shown i.s representative 
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Figure 17. Temperature modulation of GnRH agonist binding to WT mouse 
GnRHRs 
Intact a.T3-1 cells in 35 mm culture dishes were allowed to bind 1251-[D-Aia6]GnRH at 
either 4°C first (C) or 37°C first (•), for various time-points, followed by a shift to the 
opposite temperature, for various time-points. At . each time-point the cells were 
washed rapidly with ice-cold PBS, and then solubilized in 1 N NaOH to determine 
the total amount of radioligand bound. Non-specific binding determined in the 
presence of 100 nM unlabeled Antagonist 26 has been subtracted from the data. 
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Figure 18. Temperature modulation of GnRH agonist binding to WT, D138N, 
and R139Q mouse GnRHRs 
Intact COS-1 cells expressing mWT (•), m0138N (0), and mR139Q (A) GnRHRs 
were incubated with agonist radioligand 1251-[D-Aia6]GnRH for 3 hrs at 4°C, after 
which they were warmed to 37°C and incubated for the indicated times without-
changing the medium, then acid-washed to determine surface-bound radioligand. 
Cells shown at t = 0 were acid-washed without warming to 37°C. Non-specific 
binding determined in parallel using untransfected COS-1 cells has been subtracted 
at each time-point. Data points represent the mean ± S.E.M. of three independent 
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Figure 19. Time-course of binding of 1251-[D-AiaiGnRH at 4°C 
Intact aT3-1 cells which endogenously express mWT GnRHRs (•) were incubated 
with the agonist radioligand 1251-[D-Aia6]GnRH (105 cpm/well) for the times shown at 
4°C. Cells were then washed, solubilized in 1 N NaOH and the total radioactivity 
counted in a y-counter. Non-specific binding determined in the presence of 100 nM 
unlabeled Antagonist 26 has been subtracted from the data. The experiment shown 
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Figure 20. Optimization of acid-wash conditions for 1261-(D-Aia1G'nRH 
Intact COS-1 cells expressing mWT GnRHRs were incubated with the agonist 
radioligand 1251-[D-Aia6]GnRH for 3 hrs at 0°C. Cells were washed twice rapidly with 
ice-cold PBS followed by the indicated wash (also ice-cold), which was collected. 
The cells were then solubilized in 1 N NaOH. The two fractions were counted in a y-
counter and the acid-sensitive radioactivity expressed. Non-specific binding 
determined in parallel using untransfected COS-1 cells h?ts been subtracted from the ·· 
data. The experiment shown is representative of two independent experiments 
performed in duplicate. 
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Figure 21. Time-course of binding of 1251-Antagonist 26 at 4°C 
Intact aT3-1 cells which endogenously express mWT GnRHRs (•) were incubated 
with the agonist radioligand 1251-Antagonist 26 (105 cpm/well) for the times shown at 
4°C. Cells were then washed, solubilized in 1 N NaOH and the total radioactivity 
counted in a y-counter. Non-specific binding determin~d in the presence of 1 00 nM 
unlabeled Antagonist 26 has been subtracted from the data. The experiment shown 
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Figure 22. Optimization of acid-wash conditions for 1251-Antagonist 26 
Intact aT3-1 cells which endogenously express mWT GnRHRs were incubated with 
the antagonist radioligand 1251-Antagonist 26 for 3 hrs at 0°C. Cells were washed 
twice rapidly with ice-cold PBS followed by the indicated wash (also ice-cold), which 
was collected. The cells were then solubilized in 1 N NaOH. The two fractions were 
counted in a y-counter and the acid-sensitive radioactivity expressed. Non-specific 
binding determined in the presence of 100 nM unlabeled Antagonist 26 has been 
subtracted from the data. The experiment shown is representative of two 
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Figure 23. Comparison of internalization of agonist- and antagonist-occupied 
GnRH receptors (DAB cross-linking method) 
Internalization of 1251-Antagonist 26 (left panel) and 1251-[D-Aia6]GnRH (right panel) in 
COS-1 cells expressing mWT GnRHRs was determined by the DAB cross-linking 
method as described in Section 2.7. Internalized radioligand is expressed as % of 
total cell-associated radioligand. Non-specific binding determined in the presence of 
1 00 nM unlabeled Antagonist 26 has been subtracted from the data. Data points are 
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Figure 24. Acid-sensitive and -resistant 1251-[0-Aia61GnRH fractions from 
untransfected COS-1 cells and COS-1 cells expressing WT mouse GnRHRs 
(acid-wash method) 
Acid-sensitive and acid-resistant 1251-[D-Aia6]GnRH fractions from untransfected 
COS-1 cells (D) and COS-1 cells expressing mWT GnR.HRs (•) were determined by 
the acid-wash method as described in Section 2.7. Data points are the mean ± 
S.E.M. of a single representative experiment performed in triplicate. This figure is 
included to demonstrate the non-specific components (D) in the acid-sensitive and 
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Figure 25. Internalization of 1251-[D-Aia61GnRH mediated by WT, D138N, and 
R139Q mouse GnRHRs (acid-wash method) 
Internalization of 1251-[D-Aia6]GnRH in COS-1 cells expressing mWT (•). mD138N 
(0), and mR139Q (A) GnRHRs was determined by the acid-wash method as 
described in Section 2.7. lnternalize9 radioligand is expressed as % of total cell-
associated radioligand. Non-specific binding determined in parallel using 
untransfected COS-1 cells has been subtracted at each time-point. Data points are 
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Figure 26. Internalization of 1251-[D-AiaiGnRH mediated by WT, D138N, and 
R139Q mouse GnRHRs (DAB cross-linking method) 
Internalization of 1251-[D-Aia6]GnRH in COS-1 cells expressing mWT (•), mD138N 
(0), and mR139Q (A) GnRHRs was determined by the DAB cross-linking method as 
described in Sectio~ 2.7. Internalized radioligand is expressed as ~ of total cell-
associated radioligand. Non-specific binding determined in parallel using 
untransfected COS-1 cells has been subtracted at each time-point. Data points are 
the mean± S.E.M. of three independent experiments performed in triplicate. 
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Figure 27. Effect of phorbol ester on agonist-promoted internalization of WT 
and R139Q mouse GnRHRs 
Internalization of 1251-[D-Aia6]GnRH in COS-1 cells expressing mWT GnRHR in the 
absence (•) and presence (D) of PMA, and mR139Q GnRHR in the absence (•) 
and presence (A) of PMA, was determined by the acid-wash method as described in 
Section 2.7. Cells were pre-incubated for 1 hr at 37°C with 100 nM phorbol 12-
myristate 13-acetate before the addition of radioligand. Non-specific binding 
determined in parallel using untransfected COS-1 cells has been subtracted at each 
time-point. Data points are the mean ± S.E.M. of two independent experiments 
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Figure 28. Internalization of 1251-[D-AiaiGnRH mediated by WT, 1143A, and 
1143L human GnRHRs 
Internalization of 1251-[D-Aia6]GnRH in COS-1 cells expressing hWT (•), hi143A (0), 
and hi143L (L\) GnRHRs was determined by the acid-wash method as described in 
Section 2.7. Internalized radioligan~ is expressed as a % of total cell-associated 
radioligand. Non-specific binding determined in parallel using untransfected COS-1 
cells has been subtracted at each time-point. Data points are the mean± S.E.M. of 
three independent experiments performed in triplicate. 
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Figure 29. Models for G protein-coupled receptor activation 
Schematic arrangement of the (a) arginine switch model of Oliveira et al., 1994, (b) 
model of Scheer et al., 1996, and (c) arginine cage model of Ballesteros et al., 1998. 
The seven helix bundle is viewed from the cytosolic side, and the helices are shown 
as cylinders. The angle of the helices are arbitrary. The shaded area represents the 
. . 
highly polar pocket formed between Asn 1'50, Asp2·50, Asp7.49, and Tyr7'53 as described 
in text. The alternative positions of the arginine side-chain are connected by an 
arrow. 
(a) Model of Oliveira et al., 1994 
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Figure 29. (continued). Models for G protein-coupled receptor activation 
(b) Model of Scheer et al., 1996 
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Figure 30. Sequence of the chicken GnRH receptor cytoplasmic tail mutants 
The top line shows the sequence of the wild type chicken GnRH receptor C-terminal 
cytoplasmic tail. Sequence of the truncated mutants and of the point mutations are 
indicated below; the mutated amino acids are shown in bold-print. 












Figure 31. Time-course of binding of 1251-[His5, D-Tyr1GnRH 
Intact COS-1 cells expressing hWT (•). and cWT (0) GnRHRs were incubated with 
the agonist radioligand 1251-[His5, D-Tyr6]GnRH (105 cpm/well) for 6 hrs at ooc. Pt. 
various time-points cells were washed, solubilized in 1 N NaOH and the bound 
radioactivity counted. Non-specific binding determined in parallel using 
untransfected COS-1 cells has been subtracted at each time-point. The experiment 
shown is representative of two independent experiments performed in duplicate. The 
binding affinities (~) for [His5 , D-Tyr6]GnRH for hWT and cWT receptors were, 5.07 
nM and 3.28 nM respectively, while the calculated receptor numbers were 54.3±1.8 
and 60.1±9.2 fmol/well respectively (~ values and receptor numbers were 
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Figure 32. Comparison of internalization of WT human, WT chicken, and 
S337stop chicken GnRHRs 
Internalization of 1251-[His5, D-Tyr6]GnRH in COS-1 cells expressing hWT (•). cWT 
(D), and cS337stop (0) GnRHRs was determined by the acid-wash method as 
described in Section 2. 7_. Non-specific binding determined in parallel . using 
untransfected COS-1 cells has subtracted at each time-point. Data points are the 
mean± S.E.M. of four independent experiments performed in triplicate. 
(a) Internalized radioligand expressed as a% of total cell-associated radioligand. 
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Figure 32. (continued) Comparison of internalization of WT human, WT 
chicken, and S337stop chicken GnRHRs 
(c) Surface-bound radioligand 
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Figure 33. Internalization of 126HHis6, 0-TyriGnRH mediated by chicken 
GnRH receptors with truncations of the C-terminal tail 
Internalization of 1251-[His5, D-Tyr6]GnRH in COS-1 cells expressing cWT (•), 
cS337stop (0), cS346stop (A), cT351stop (V), cD356stop (e), cS366stop 
(.._)GnRHRs was determined by the acid-w~sh method as described in Section 2.7. 
Internalized radioligand is expressed as a % of total cell-associated radioligand. 
Non-specific binding determined in parallel using untransfected COS-1 cells has 
been subtracted at each time-point. Data points are the mean ± S.E.M. of two to 
three independent experiments performed in triplicate. 
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Figure 34. Effect of progressive truncations of cytoplasmic tail of chicken 
GnRH receptor on internalization and recycling rate constants 
Internalization (•) and recycling (D) rate constants were calculated using equations 
9 and 10 (see Section 2.9.1 ). 
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Figure 35. Internalization of 1251-[His5, D-Tyr61GnRH mediated by chicken 
GnRH receptors with point-mutations of Ser/Thr residues in the C-terminal tail 
Internalization of 1251-[His5, D-Tyr6]GnRH in COS-1 cells expressing cWT ( ), 
cS337A (0), cT362S363---)AA (~). cS366A (V), cT369T370---)AA (e) GnRHRs was 
determine~ by the acid-wash method as described in Se.ction 2.7. Internalized 
radioligand is expressed as a % of total cell-associated radioligand. Non-specific 
binding determined in parallel using untransfected COS-1 cells has been subtracted 
at each time-point. Data points are the mean± S.E.M. of two to three independent 
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Figure 36. Internalization of 1251-[His5, D-TyriGnRH mediated by WT chicken, 
GnRHR in the presence of co-expressed WT dynamin I and mutant dynamin 1-
K44A 
Internalization of 1251-[His5, D-Tyr6]GnRH in COS-1 cells expressing cWT (•). cWT + 
dynamin I (0.5 Jlg DNA, ratio of 0.5 : 0 .. 5 dynamin:cGnRHR) (0), and cWT + 
dominant-negative mutant dynamin I-K44A (0.5 Jlg DNA, ratio of 0.5 : 0.5 
K44A:cGnRHR) (.1) was determined by the acid-wash method as described in 
Section 2.7. Internalized radioligand is expressed as a % of total cell-associated 
radioligand. Non-specific binding determined in parallel using untransfected COS-1 
cells has been subtracted at each time-point. Data points are the mean± S.E.M. of 
three independent experiments performed in triplicate. 
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Figure 37. Internalization of 1251-[His5, D-TyriGnRH mediated by WT chicken, 
human. and truncated chicken GnRHRs in the presence of co-expressed 
dominant-negative mutant dynamin 1-K44A 
Internalization of 1251-[His5, D-Tyr6]GnRH for 30 min in COS-1 cells expressing cWT 
(D), hWT (•). a~d cS337stop (stripped bars), in the presence of increasing amounts 
of co-transfected mutant dynamin I-K44A, was determined by the acid-wash method 
as described in Section 2.7. Internalized radioligand is expressed as a % of the 
internalization of the cWT receptor in the absence (0 f.lg) of co-transfected mutant 
dynamin I-K44A. Non-specific binding determined in parallel using untransfected 
COS-1 cells has been subtracted from the data. Data points are the mean± S.E.M. 





















Figure 38 Theoretical receptor internalization curves 
Curves were generated from the model described in Section 2.9.1 in which receptor 
trafficking is treated in terms of an internalization rate constant, k2 , and a recycling 
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Figure 39. SDS-PAGE autoradiograph of photoaffinity labeled mWT GnRH 
receptors endogenously expressed on intact aTJ-1 cells 
Intact a T3-1 mouse pituitary cells were photoaffinity labeled (Section 2.8.1) and the 
membranes were solubilized in 1% Trition X-1 00 and stored at -70°C (lanes 1 and 
2), or deglycosylated (37°C, 18 hrs) with peptide N-glycosidase F (PN-gase F, 8 













Figure 40. The effect of protease inhibitors on degradation of photoaffinity 
labeled GnRH receptors endogenously expressed on intact a.T3-1 cells 
Intact a.T3-1 mouse pituitary cells were photoaffinity labeled (Section 2.8.2) and the 
labeled membranes were incubated at 3JCC in the absence or presence of the 
protease inhibitors, leupeptin (0.1 mM) and PMSF (1 mM), for the indicated time-
points, before solubilization, followed SDS-PAGE and autoradiography. Pairs of 
lanes represent duplicate samples. 
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Figure 41. Stability of the covalent cross-link between photoaffinity ligand 
and GnRH receptor 
The radioactivity in the GnRH receptor bands in lanes 2-10 of the gel presented in 
Figure 40 was quantitated and the data fitted by non-linear regression to a 
exponential decay equation, yielding a value of 0.05%.min-1 for the in vitro decay 
rate constant, corresponding to a half-life of 23.2 hrs. Data points are the mean ± 
S.E.M. of duplicate samples in a single experiment. 
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Figure 42. The effect of protease inhibitors on degradation of photoaffinity 
labeled GnRH receptors endogenously expressed on intact a.T3-1 cells 
Intact a.T3-1 mouse pituitary cells were photoaffinity labeled (Section 2.8.2) and the 
labeled membranes incubated at 37°C in the absence or presence of the protease 
inhibitors, leupeptin (0.1 mM), PMSF (1 mM), and EDTA (1 mM), for the indicated 
time-points. Membranes were then solubilized and subjected to SDS-PAGE and 
autoradiography. Pairs of lanes represent duplicate samples. 
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Figure 43. The effect of heat pre-treatment on degradation of photoaffinity 
labeled GnRH receptors endogenously expressed on intact aT3-1 cells 
Intact a T3-1 mouse pituitary cells were photoaffinity labeled (Section 2.8.2) and the 
labeled membranes incubated at 37°C for the indicated time-points. In lanes 1-4 a 
10 min heat inactivation step (60°C) was added prior to incubation at 37°C. 
Following incubation at 37°C, membranes were solubilized and subjected to SDS-
PAGE and autoradiography. Pairs of lanes represent duplicate samples. 
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Figure 44. Intracellular degradation of 1251-[N-azidobenzoyi-D-LysSIGnRH 
cross-linked receptor invivo 
SDS-PAGE autoradiograph of photoaffinity labeled GnRH receptors endogenously 
Elxpressed on intact aT3-1 cells. Following UV irradiation and cross-linking of 1251-[N-
azidobenzoyi-D-Lys6]GnRH, cells were incubated at 37°C . in HEPES/DMEM for the 
indicated times, after which they were processed as described in Section 2.8.3. 
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Figure 45. Intracellular degradation of 1251-[N-azidobenzoyi-D-LysS,GnRH 
cross-linked receptor in vivo 
125HN-azidobenzoyi-D-Lys6]GnRH radioactivity in gel bands as labeled GnRH 
receptor (•), radioactivity released into the medium (D), and total radioactivity at 
each time-point (0) is shown for the experiment in Figure 44. The experiment was 
performed as described in Section 2.8.2. Data points are the mean ± S.E.M. of 
duplicate dishes in a single experiment. 
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